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vAbstract
Activity plays diverse roles in shaping neuronal development and function. These 
roles range from aiding in synaptic refinement to triggering cell death during traumatic 
brain injury. Though the importance of activity-dependent mechanisms is widely 
recognized, the genetic underpinnings of these processes have not been fully described. 
In this thesis, I use the motor circuit of Caenorhabditis elegans as a model system to 
explore the functional and morphological consequences of modulating neuronal activity.   
First, I used a gain-of-function ionotropic receptor to hyperactivate motor neurons 
and asked how increased excitation affects neuronal function. Through this work, I 
identified a cell death pathway triggered by excess activation of motor neurons.  I also 
showed that suppression of cell body death failed to block motor axon destabilization, 
providing evidence that death of the cell body and of motor axons can be genetically 
separated.  
Secondly, I removed excitatory drive from a simple neural circuit and asked how 
loss of excitatory activity alters circuit development and function.  I identified excitatory 
motor neurons as master regulators of inhibitory synaptic connectivity.  Additionally, I 
was able to identify previously undescribed activity-dependent mechanisms for 
regulating inhibitory synapses in both developing and mature neural circuits.   
Finally, I show data to implicate the highly conserved genes neurexin and 
neuroligin in determining inhibitory synapse connectivity. Collectively this work has lent 
insight into activity-dependent mechanisms in place to regulate neuronal development 
vi
and function, a core function of neurobiology that is relevant to the study of a wide range 
of neurological disorders.   
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CHAPTER I 
 
General Introduction 
  
2Neuronal activity impacts a wide array of events in nervous system development 
and function.  For example, patterned bursts of activity during early development are 
required for the refinement of neural networks (reviewed in Blankenship and Feller, 
2010) and over activation of neurons during trauma, such as ischemic stroke, can lead to 
neurodegeneration (Arundine and Tymianski, 2004). In this thesis, I explore the 
functional consequences of altered excitatory activity within the nervous system in two 
ways: In Chapter II, I express a gain-of-function ionotropic receptor in cholinergic motor 
neurons and ask how increased excitation affects neuronal function.  In Chapter III, I 
remove excitatory drive from a simple neural circuit and ask how loss of excitatory 
activity alters circuit development and function.  In order to address these questions, I 
used the nematode Caenorhabditis elegans, which has a tractable motor circuit where 
activity can be easily modulated.  
 
Excitotoxic cell death 
Many studies have implicated hyperactivation of neurons through ionotropic 
receptors as a key factor that leads to excitotoxic cell death (Heintz, 2000). For example, 
hyperactivation of NMDA and AMPA receptors can lead to high levels of calcium in the 
cytoplasm, which triggers neurotoxic pathways within the cell (Szydlowska and 
Tymianski, 2010). This principle was explored in a series of knock-in mouse experiments 
where the pore spanning regions of various brain nicotinic acetylcholine receptor 
(nAChR) subunits were modified, leading to increased activation of the receptor (Orr-
Urtreger et al., 2000); (Labarca et al., 1995); (Orb et al., 2004). This receptor activation 
3led to significant loss of neurons and perinatal lethality, suggesting that increasing 
receptor signaling is sufficient to trigger cell death.  Work conducted on the rat α7 
nAChR has shown that in cases of pharmacological activation, increased calcium levels 
occur prior to cell death, presumably due to a low level of calcium buffering capacity 
(Berger et al., 1998).  These studies suggest that the hyperactivation of ionotropic 
receptors is ultimately sufficient to induce cell body death. 
Ion channel-mediated cell death in C. elegans has been extensively characterized 
using a gain-of-function mutant of the degenerin/epithelial Na (DEG/ENaC) channel 
mec-4, which causes cell-autonomous death in all six mechanosensory neurons (Hong 
and Driscoll, 1994). Interestingly, mec-4 is also capable of inducing cell death in motor 
neurons when ectopically expressed, suggesting that different neuronal types share 
common cell death pathways (Xu et al., 2001b). Morphological characterization of 
neuronal cell bodies in mec-4(d) mutants shows striking similarities to the changes 
observed in the organelles of mammalian neurons undergoing cell death. Electron 
microscopy in young animals shows subtle changes in the cellular morphology prior to 
the onset of cell death-associated behavioral changes (Hong and Driscoll, 1994) including 
the appearance of an electron dense ring around the nucleus, swollen mitochondria and 
disruption of the plasma membrane.  By the onset of late stage degeneration, large 
vacuolar lesions within the cell body, chromatin aggregation and swelling of the ER 
occur, eventually leading to a complete breakdown of organelles and cell death 
(Tymianski et al., 1993).  Similar phenotypes have been observed in mammalian models 
of excitotoxicity, where increased calcium levels lead to DNA fragmentation, 
4mitochondrial swelling and cellular membrane disruption (Szydlowska and Tymianski, 
2010).  
A forward genetic screen revealed a major role for calcium channels in the ER and 
the protein folding chaperone calreticulin in mediating cell body death in cases of mec-
4(d)-induced degeneration (Flanagan-Steet et al., 2005). Calreticulin is primarily 
localized to the lumen of the endoplasmic reticulum and it acts to regulate calcium stores 
within the ER (Michalak et al., 1999). This genetic screen identified three other genes 
required for regulating calcium homeostasis in the ER: the calcium regulator calnexin 
(Wada et al., 1991), the calcium release channel inositol triphosphate receptor channel 
itr-1 (Baylis et al., 1999) and the ER calcium release channel ryanodine receptor channel 
unc-68 (Maryon et al., 1996). These studies support the hypothesis that calcium 
homeostasis plays an important role in regulating cell body death during excitotoxicity, 
but they do not address potential early events in excitotoxic damage such as axonal 
degeneration and synapse loss.  
In this thesis, I use a gain-of-function ionotropic acetylcholine receptor in cholinergic 
motor neurons to carry out genetic analysis of genes required for motor neuron 
degeneration in cases of hyperactivation.  Through this work, I show evidence that motor 
axon cell death is genetically separable from cell body death, lending potential insight 
into mechanism of axon dysfunction in neurodegenerative diseases. 
 
Ionotropic Acetylcholine Receptors 
 
 Henry Hallett Dale first identified acetylcholine (ACh) in a 1914 study to 
determine the chemical nature of synaptic transmission. Otto Loewi later confirmed the 
5role of ACh as a neurotransmitter with his work on the vagus nerve (Fishman, 1972). 
This work resulted in a joint Nobel Prize in Physiology and Medicine in 1936 for their 
combined efforts to identify acetylcholine as the first known neurotransmitter. 
Acetylcholine is primarily an excitatory neurotransmitter that depolarizes neurons 
through the activation of either ligand gated nicotinic receptors (nAChRs) or G-protein 
coupled muscarinic receptors (mAChRs) (Dani and Bertrand, 2007).  nAChRs consist of 
five receptor subunits surrounding an aqueous ion pore that is permeable to cations upon 
activation of the channel (Figure 1-1) (McGehee and Role, 1995); (Jones et al., 1999);
(Karlin, 2002). Channel activation is achieved by the binding of acetylcholine to one of 
the channel binding sites at the junction of two alpha subunits on the extracellular face of 
the receptor. Heteromeric receptors have two binding sites while homomeric receptors 
have five (Gay and Yakel, 2007).   
The second transmembrane domain of each receptor subunit lines the ion pore 
forming the ion gate of the receptor (Albuquerque et al., 2009) (Figure 1-1).  Upon 
acetylcholine binding, the receptor undergoes a conformational change leading to a 
repositioning of hydrophobic amino acid residues of the TM2 domain, which are replaced 
with more hydrophilic residues, allowing ions to pass through the pore. The TM2 domain 
is essential for establishing the channel gate, ion selectivity and channel conductance of 
the acetylcholine receptor (Albuquerque et al., 2009).  Mutations in the amino acid 
sequence of the TM2 pore domain can alter properties of the ion gate resulting in an 
increase in channel permeability, a phenomenon seen in certain types of epilepsy 
(Kuryatov et al., 1997); (Lester et al., 2003).  
6A wide variety of nAChR subtypes arise from the combination of different 
receptor subunits, as the activation and desensitization kinetics of these receptors are 
directly influenced by the amino acid sequences within individual subunits (Jensen et al., 
2005).  The diversity of receptor subtypes, and their localization contribute to the variety 
of functions they perform in the nervous system.   In the mammalian nervous system, 
synaptically localized AChRs are located primarily at the neuromuscular junction and 
within the autonomic ganglion but are rarely found in the CNS (Changeux, 2010).  In the 
mammalian CNS, AChRs are primarily extrasynaptic and they modulate neuron 
excitability, regulate presynaptic release of neurotransmitters and coordinate the firing of 
neuron groups  (Kawai et al., 2007); (Wonnacott, 1997); (Rice and Cragg, 2004); Zhang 
and Sulzer, 2004, #26132}. Through my work I have developed a novel method for the 
identification of AChR subunit composition and accessory proteins required for receptor 
localization. 
Both nAChR and mAChRs have been linked to synaptic plasticity in the 
mammalian brain (Cobb and Davies, 2005); (Fujii and Sumikawa, 2001); (Ji et al., 2001); 
(Maylie and Adelman, 2010); (McGehee, 2002). For example, activation of alpha-7 
containing receptors on presynaptic terminals can facilitate long term potentiation (LTP), 
the cellular basis of learning and memory, in pyramidal cells within the hippocampus (Ji 
et al., 2001).  
7Figure 1-1: The structure of nicotinic acetylcholine receptors 
A: Homomeric receptor viewed from extracellular side.  Homomeric receptors consist of 
five alpha subunits arranged around an aqueous ion pore.  Acetylcholine binding sites are 
located at the junction between subunits.  B: Heteromeric receptor viewed from 
extracellular side.  Heteromeric receptors consist of two alpha subunits and one each of β, 
γ and δ subunits.  Acetylcholine binding sites are located at the α-γ and α-δ junctions. C: 
Four transmembrane domain composition of a single nAChR subunit with the pore-
spanning TM2 domain in green.  D: Subunit arrangement around the ion pore.  The pore-
spanning TM2 subunit domains are indicated in green.  
  

9Defects in cholinergic signaling in the hippocampus have been linked to a variety of 
learning and memory disorders including Alzheimer’s disease, schizophrenia and 
epilepsy. (Dani and Bertrand, 2007); (Terry and Buccafusco, 2003). 
 
Activity dependent neural circuit assembly and E/I balance 
 During development, a sculpting and refinement period occurs after axon 
guidance during which neurons hone their synaptic connections to form functional neural 
circuits (Katz and Shatz, 1996). Spontaneous activity within circuits play a critical role in 
this refinement period, with correlated spontaneous activity observed in areas of the brain 
including the retina, cochlea, spinal cord, cerebellum, hippocampus and neocortex 
(Blankenship and Feller, 2010); (Dehorter et al., 2012); (Feldt et al., 2011); (Moody and 
Bosma, 2005). It is proposed that activity during this time works to drive circuit 
refinement by strengthening and weakening connectivity between neurons (Balice-
Gordon and Lichtman, 1994); (Goda and Davis, 2003). For example, repeated stimulation 
of postsynaptic cells by presynaptic activity causes strengthening of the synapse or long-
term potentiation (LTP) while weak stimulation leads to depression of the synapse or 
long-term depression (LTD) in a process termed Hebbian Plasticity (Katz and Shatz, 
1996).   It is essential that excitatory and inhibitory signals within the network remain 
balanced (E/I balance) throughout these periods of refinement to enable appropriate 
neural circuit connectivity and brain function (Gatto and Broadie, 2010).  
One of the most extensively studied family of disorders linked to E/I balance are 
the Autism Spectrum Disorders (ASD).  This family of neurodevelopmental diseases is 
10
characterized by compromised communication and social skills and reduced cognition.  
The early onset of these symptoms suggests that defects occur during fetal or early 
postnatal development.  Studies on autism models have shown that the increased ratio of 
excitation/inhibition in the sensory, mnemonic social and emotional systems, leads to 
increased waves of excitation during development, which causes missed critical periods 
resulting in an unstable circuit in the mature brain (Rubenstein and Merzenich, 2003).   
GABA interneurons comprise 10-25% of cortical neurons in the adult brain and play 
an essential role in regulating activity levels of pyramidal neurons (Le Magueresse and 
Monyer, 2013).  In addition to controlling cortical activity in the adult brain, GABA 
neurons also help maintain E/I balance in the developing cortex.  The development of the 
GABA nervous system begins prior to the establishment of release sites in glutamatergic 
neurons, and continues throughout normal synaptogenesis, suggesting a role for GABA 
in regulating synaptic development (Verhage et al., 2000).   This is supported by work in 
rodent models, which shows that blocking GABA release during early development 
results in a permanent decrease in excitatory synaptic transmission and excitatory 
dendrite length in the adult nervous system (Wang and Kriegstein, 2008); (Wang and 
Kriegstein, 2011).  Additionally, altering the timing of the switch between excitatory and 
inhibitory GABA signaling leads to changes in dendritic morphology, illustrating the 
importance of GABA signaling in the development of cortical circuits (Cancedda et al., 
2007).  
During postnatal development, GABA interneurons act as pacemakers for other 
cortical neurons, which is a function they maintain in the adult brain. Inhibitory drive 
11
during this period is critical for the establishment of adult oscillation patterns, which 
control network refinement during postnatal critical periods.  The best described critical 
period in activity-dependent circuit refinement is for ocular dominance, in which closure 
of one eye during periods of synaptic refinement leads to an increased field for the 
uncovered eye at the expense of the covered eye (Wiesel and Hubel, 1963).  Blocking 
GABA activity during this ocular dominance paradigm either pharmacologically (Reiter 
and Stryker, 1988) or genetically (Hensch et al., 1998) blocks this change in territory, 
indicating that a threshold amount of GABA release is required for synaptic refinement. 
Synaptic wiring and neural circuit architecture are also directly shaped by GABAergic 
transmission in late cortical development (Hensch and Stryker, 2004); (Oray et al., 2004);
(Mataga et al., 2004). Collectively, these studies show that GABA neuron function is 
essential for the establishment of nervous system connectivity.   
Once initial nervous system connectivity is established, homeostatic mechanisms 
are in place to maintain circuit function within a tolerable range. These mechanisms 
prevent hyperexcitation of neurons, which maintains brain function. Homeostatic 
mechanisms that maintain circuit activity within a specific dynamic range have been 
described in many systems (Turrigiano and Nelson, 2004); (Davis, 2006); (Maffei and 
Fontanini, 2009), and disruption of these mechanisms has been linked to a large number 
of neuropsychiatric and neurodevelopmental disorders ranging from schizophrenia to 
autism (Gatto and Broadie, 2010); (Kehrer et al., 2008); (Wassef et al., 2003).  Though 
many studies have identified disruption of E/I balance as a key component of 
12
neurological disorders, many questions remain about the mechanisms required to 
maintain this balance in the developing nervous system.  
 
Activity dependent remodeling of circuits 
In mammals, mature neuromuscular junctions (NMJ) consist of muscle cells that 
receive input from a single motor neuron (Brown et al., 1976). Activity dependent 
synapse editing plays an important role in regulating the number of motor neurons 
synapsing onto each muscle cell.  The mechanisms underlying this editing are not fully 
understood, but it is believed that retrograde signals from the post-synaptic muscle cells 
work to modulate the activity of pre-synaptic motor neurons (Balice-Gordon et al., 1993). 
One class of proteins that has been identified as an activity dependent messenger in NMJ 
formation is the TGFβ family of proteins.  This family consists of TGFβ, bone 
morphogenic proteins (BMPs) and activins that are secreted by motor neurons, glia and 
muscle in mammals.  Studies on BMP function at the Drosophila NMJ have shown that 
mutations in either the BMP ligand or the BMP receptors lead to presynaptic defects such 
as a reduced number of NMJs and impaired neurotransmitter release (Marques et al., 
2002); (McCabe et al., 2004).  Postsynaptic morphology is unaltered in these animals, 
suggesting that the TGFβ family act as retrograde messengers at the NMJ (Aberle et al., 
2002). 
 A second class of proteins that have been implicated in retrograde signaling at the 
NMJ is the Wnt family of proteins.  At the mammalian NMJ, Wnt3a functions through 
the canonical β-catenin pathway to decluster acetylcholine receptors (Henriquez et al., 
13
2008).  In addition to receptor declustering, activation of β-catenin leads to a retrograde 
signal that controls mechanisms of pre-synaptic assembly (Li et al., 2008).  In Drosophila, 
the Wnt wingless and its receptor frizzled-2 play important roles in NMJ development.  
Wingless is secreted by motor neurons and activates signaling cascades, which work to 
form the neuromuscular synapse (Packard et al., 2003).   
Evidence of activity-dependent synapse remodeling has also been demonstrated in 
C. elegans.  During the transition from the first to second larval stage, the six GABAergic 
DD motor neurons switch polarity from receiving input dorsally and project ventrally to 
receiving input ventrally and project dorsally (White et al., 1978); (Thompson-Peer et al., 
2012).  During this switch, presynaptic terminals are disassembled on the ventral side and 
new synapses are formed on the dorsal processes (Hallam and Jin, 1998). The timing of 
this switch in innervation is directly tied to activity within the motor circuit, as mutations 
that increase or decrease circuit synaptic release alter the timing of remodeling 
(Thompson-Peer et al., 2012). Through the combined effort of multiple labs, some of the 
molecular mechanisms underlying this process have begun to be described.  
During DD remodeling, the elimination of GABA presynaptic terminals in the 
ventral nerve cord and establishment of new release sites in the dorsal nerve cord occurs 
simultaneously.  This process is mediated by expression of cyy-1, which encodes a cyclin 
box-containing protein that removes presynaptic proteins from the ventral nerve cord, and 
cdk-5, which encodes a cyclin-dependent kinase that facilitates trafficking to new 
synaptic sites (Park et al., 2011).   Animals carrying single mutations in either of these 
genes show delayed, incomplete remodeling, while the double mutant animals fail to 
14
remodel.  Simultaneous reintroduction of cyy-1 and cdk-5 later in development triggers 
remodeling suggesting that remodeling is initiated by cyy-1 and cdk-5 expression (Park et 
al., 2011).  
Unlike the DD motor neurons, the GABAergic VD motor neurons do not undergo 
a remodeling process.  Remodeling in these neurons is inhibited by expression of the 
transcription factor unc-55 (Shan et al., 2005).  unc-55 encodes the sole homolog of the 
COUP-TF nuclear hormone receptor family in C. elegans that has shown to play wide 
roles in the development of the mammalian nervous system (Zhou and Walthall, 1998);
(Armentano et al., 2007); (Tomassy et al., 2010).  This transcription factor is thought to 
function by regulating the activity of genes required for the remodeling of DD motor 
neurons.  One of the downstream targets that has been characterized is the conserved 
homeodomain-transcription factor irx-1/Iroquois (Petersen et al., 2011).  Loss of irx-1 
results in delayed DD remodeling, but is unable to completely block the process.  This 
suggests that parallel pathways must be in place to regulate the synaptic remodeling 
process.  
 DD remodeling has been linked to neuronal activity through hbl-1 (hunchback-
like-1), a transcription factor, which is active in DD neurons but is repressed in VD 
neurons by unc-55 (Fay et al., 1999); (Thompson-Peer et al., 2012).   Animals carrying 
loss of function mutations in hbl-1 show delayed DD remodeling, though the timing of 
related cell fates remains unchanged.  Genetic analysis showed that changes in activity 
levels correlated to changes in hbl-1 expression in the DD neurons.  Decreased circuit 
activity results in decreased hbl-1 expression, ultimately leading to delayed DD 
15
remodeling (Thompson-Peer et al., 2012).  These results show that changes in hbl-1 
expression are required to modulate activity-dependent changes in the timing of 
inhibitory synaptic remodeling.  This system shows evidence for activity-dependent 
control of neuronal development in C. elegans but the role of activity in the initial 
establishment of synaptic fields remains uncharacterized.  
 
C. elegans as a model system to study nervous system function 
Sydney Brenner first proposed the use of the soil-dwelling nematode Caenorhabditis 
elegans as a model system for studying the nervous system in 1963.  He published a 
paper detailing techniques for conducting forward genetic screens and identifying genetic 
mutations, which established C. elegans as a viable genetic model for studying nervous 
system function and behavior (Brenner, 1974a).   The highly simplified nervous system 
of C. elegans consists of only 302 neurons with well-established connectivity (Ward et al., 
1975; White et al., 1976), allowing for the study of neural networks.  Additionally, the 
genome of C. elegans has been fully sequenced and highly annotated, and there are 
mutants of many genes available. The combination of well-defined connectivity and 
genetic tools makes C. elegans an ideal model for the study of neural circuit development 
and function.  
The genome of C. elegans contains high levels of homology to mammalian genes, 
enabling the study of medically relevant genetic pathways in a convenient and tractable 
system. The ability of C. elegans to self-fertilize allows the study of genetic mutations 
that render the nervous system non-functional, many of which are lethal in other systems.  
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Furthermore, transgenic strains can be generated quickly and easily in this system (Mello 
et al., 1991a), allowing targeted genetic manipulation and tagging of specific proteins 
with genetically encoded fluorescent markers.  These fluorescently marked strains are 
especially useful because the C. elegans cuticle is transparent, which allows the study of 
neuronal morphology and protein localization in a fully intact nervous system. In vivo 
electrophysiological techniques in C. elegans make it possible to directly monitor 
functional changes at synapses that occur as a result of genetic manipulations. This 
combination of tools has already been used to address fundamental questions in 
neurobiology and provided an ideal system for my study of the role of activity in nervous 
system development and dysfunction.  
 
The C. elegans motor circuit 
 The structure of the C. elegans motor circuit was initially described in the Brenner 
Lab as part of an extensive electron microscopy reconstruction project spearheaded by 
John White.  The motor neurons were organized into five classes and described based on 
neuronal morphology and connectivity within the circuit.  These motor neuron classes 
have distinct, non-overlapping domains and are connected to members of their own class 
by gap junctions (White et al., 1976).   
 More recent work has characterized the five classes of motor neurons initially 
described by White as either inhibitory GABAergic motor neurons (VD/DD) or 
excitatory cholinergic motor neurons (VA, DA, VB, DB and VC), where V- indicates 
ventral innervation and D- indicates dorsal innervation.   In the functional circuit, 
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interneurons activate excitatory cholinergic motor neurons that form synapses onto both 
body wall muscle and inhibitory GABA motor neurons.  Depolarization of body wall 
muscle by cholinergic innervation results in muscle contraction.  GABA motor neurons 
project to the contralateral musculature where they form synapses with body wall muscle, 
causing relaxation (Figure 1-2). The C. elegans genome does not encode voltage gated 
sodium channels, resulting in a lack of classical sodium action potentials in this process.  
Instead, motor neurons signal through graded release mechanisms, which are determined 
by the size of the depolarizing stimulus, resulting in high frequency bursts of postsynaptic 
currents lasting between 7s and 3min -1 in wild type worms (Liu et al., 2009). The 
bursting activity of motor neurons results in action potential firing in body wall muscles 
(Liu et al., 2013) leading to muscle contractions.  The balance of excitation and inhibition 
across muscle quadrants coordinates the characteristic sinusoidal body bend pattern of C. 
elegans.  
 
The C. elegans Neuromuscular Junction 
At the C. elegans neuromuscular junction (NMJ), muscles extend projections 
called muscle arms to the nerve cord where they form en passant synapses with motor 
neuron axons (Figure 1-3).  Ionotropic receptors are clustered opposite release sites at the 
tips of muscle arms where they form neuromuscular junctions.  Two receptor classes 
mediate excitatory cholinergic signaling in muscle, a group of nicotine sensitive 
acetylcholine receptors (N-AChRs), and a group of levamisole-sensitive acetylcholine 
receptors (L-AChRs).  The N-AChR is homomeric, consisting of five subunits of 
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acetylcholine receptor-16 (ACR-16) (Francis et al., 2005a); (Touroutine et al., 2005).  
ACR-16 receptors are sensitive to activation by both nicotine and acetylcholine and have 
been shown to mediate the majority of cholinergic response at the NMJ ((Francis et al., 
2005a)). L-AChRs are heteromeric, consisting of five receptor subunits (unc-29, unc-38, 
unc-63, lev-1, lev-8) (Fleming et al., 1997). These receptors are referred to as levamisole 
receptors (LevR) due to their sensitivity to activation by the anthelmintic drug levamisole.  
Functional responses to acetylcholine are completely abolished in mutant animals lacking 
essential subunits of these two receptor classes (unc-29; acr-16) (Francis et al., 2005a), 
suggesting that they are the sole mediators of ACh release onto body wall muscles.  
Inhibitory transmission onto body wall muscle is mediated by a homomeric 
GABA receptor (GABAR) consisting of five subunits encoded by splice isoforms of the 
gene uncoordinated-49 (unc-49) (Bamber et al., 1999).  The unc-49 gene contains a 
single N-terminus with three alternative c-terminal splice options, which results in three 
receptor subunits (UNC-49A, UNC-49B and UNC-49C).  The UNC-49B and UNC-49C 
isoforms are highly expressed in muscle and co-localize to synaptic regions, suggesting 
that they form the functional inhibitory receptor at the C. elegans NMJ (Bamber et al., 
1999).    
During C. elegans locomotion, AChRs mediate contraction of the body wall 
muscle, while GABARs mediate inhibition of the contralateral muscle (Figure 1-2).  
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Figure 1-2: The C. elegans motor circuit 
Schematic representation of the C. elegans motor circuit. Excitatory cholinergic motor 
neurons (gray) form dyadic synapses onto body wall muscles (brown) causing 
contraction and onto inhibitory GABA motor neurons (purple), which project to the 
contralateral muscle causing relaxation.  
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Maintaining proper balance of excitation and inhibition at the NMJ is essential for the 
characteristic sinusoidal locomotion pattern of C. elegans (Jospin et al., 2009); (Schuske 
et al., 2004). The well-characterized morphology of the NMJ enables the assessment of 
changes in synapse density or patterning caused by genetic manipulations of the circuit.   
 
Development of the C. elegans motor circuit and neuromuscular junction 
The C. elegans life cycle is short and temperature-sensitive. Animals develop 
from egg to fertile adult in approximately 2.5 days at room temperature (220C).  The life 
cycle consists of an embryonic stage followed by four larval stages before adulthood.  
During late embryogenesis, approximately 6-12 hours post-fertilization at room 
temperature, progenitor cells terminally differentiate into motor neurons of the 
locomotory circuit.  
Immature muscle cells line up along the newly formed nerve cords then migrate 
away, leaving behind membrane extensions (Dixon and Roy, 2005a). These membrane 
extensions form the first muscle arms, which average 1-2 projections for each muscle cell 
(Dixon and Roy, 2005a). During the last phase of embryogenesis, the body plan of the 
animals is established and this basic organization remains largely unchanged throughout 
larval development. Larval development begins at hatch, approximately 14 hours post-
fertilization at room temperature, and consists of four stages separated by cuticle molts.  
A burst of proliferation occurs between the first and second larval stages during which an 
additional 80 neurons and 14 body wall muscles are produced (Sulston and Horvitz, 
1977).   
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Figure 1-3: The C. elegans neuromuscular junction 
Cartoon representation of the C. elegans neuromuscular junction viewed from the ventral 
side.  Cholinergic motor neurons (gray) and GABAergic motor neurons (purple) run 
along the ventral nerve cord where they form synapses onto body wall muscles.  Body 
wall muscles send membrane projections, called muscle arms (brown), to the nerve cord.  
Two cholinergic receptors (ACR-16 and LevR) as well as one GABAergic receptor 
(UNC-49) are clustered along the tips of muscle arms where they form en passant 
synapses with motor neurons. 
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During this stage, body wall muscles actively extend additional muscle arms to the nerve 
cord where they form NMJs, resulting in an average of three or four muscle arm 
extensions for each body wall muscle (Dixon and Roy, 2005a).  The outgrowth of muscle 
arms occurs through an active process by which motor neurons secrete a ligand (madd-4) 
that binds to the muscle receptor unc-40/DCC to control postsynaptic outgrowth via an 
unc-73/trio dependent pathway (Alexander et al., 2009; Seetharaman et al., 2011).   
 
Mechanisms of receptor clustering in C. elegans  
How distinct synapses are organized remains a central question in neurobiology.  
Many studies have taken advantage of the high sequence homology and genetic 
tractability of the C. elegans system to better understand mechanisms underlying synaptic 
development.  To date, most of this work has been focused on the clustering of excitatory 
AChRs at the NMJ and glutamate receptors in neurons.  Two types of acetylcholine 
receptor are found at the C. elegans NMJ: the homomeric nicotine-sensitive receptor 
ACR-16 and the heteromeric levamisole-sensitive receptor Lev-R. Each class of receptor 
is localized by distinct mechanisms.  
The localization and function of the homomeric ACR-16-containing receptor at the C. 
elegans NMJ is regulated by the gene cam-1 (Francis et al., 2005a).  cam-1 encodes a ror-
family receptor tyrosine kinase (RTK) with a high sequence homology to the mammalian 
RTK MuSK, which is associated with AChR clustering at the mammalian NMJ (Burden, 
2002); (Ghazanfari et al., 2011).  Initial observation of cam-1 loss-of-function mutants 
showed uncoordinated locomotion patterns, suggesting that cam-1 plays a role in 
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regulating synapses at the NMJ (Forrester and Garriga, 1997). CAM-1 is localized 
diffusely in the cell bodies of ACh motor neurons as well as in body wall muscle, with a 
higher concentration of protein at the tips of the muscle arms (Francis et al., 2005a). 
The functional properties of the NMJ are altered in cam-1 mutants.  Muscles are less 
responsive to ACh release and there is a reduction in the amplitude of both evoked and 
spontaneous release events, suggesting that the delivery or stabilization of ACR-16R is 
altered in the absence of CAM-1. Consistent with functional analysis, the localization of 
ACR-16-containing receptors, but not LevR or GABARs, is altered in cam-1 loss-of-
function mutants. The combination of altered kinetics of ACh response and altered 
synaptic vesicle localization in cam-1 mutant animals suggests that cam-1 also regulates 
presynaptic release (Francis et al., 2005a).  
The extracellular domain of CAM-1 contains a cysteine-rich domain that enables Wnt 
binding. Wnt proteins have conserved roles in synapse development across multiple 
systems and they play a role in a diverse set of developmental events (Budnik and Salinas, 
2011).  A recent study has linked cam-1 to Wnt signaling by identifying the C. elegans 
frizzled-like receptor lin-17 as the co-receptor for cam-1.  Together these receptors bind 
the Wnt ligand cwn-2 to instruct ACR-16 localization in the synaptic membrane (Jensen 
et al., 2012).   Expression of lin-17 is required throughout the lifespan of the animal to 
maintain appropriate localization of ACR-16 receptors. Changes in activity levels at the 
NMJ alter ACR-16 localization; this form of plasticity is cwn-2 dependent, suggesting 
that Wnts play an important role in synaptic plasticity at the C. elegans NMJ (Jensen et 
al., 2012).  
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Additional studies have identified multiple genes required for the localization of the 
levamisole-sensitive receptor at the C. elegans NMJ.  Two of the genes that have been 
well characterized are lev-9 and lev-10.  lev-9 encodes a 622 amino acid secreted protein 
consisting of a signal peptide followed by a single WAP domain and eight sushi domains 
(Gendrel et al., 2009). Localization studies indicate that LEV-9 is expressed only from 
body wall muscles and the secreted protein is localized in a punctate pattern along the 
ventral nerve cord and in the nerve ring.  These puncta co-localize with LevR markers 
and are opposed to ACh release sites, suggesting that LEV-9 localizes to the synaptic 
cleft (Gendrel et al., 2009). lev-10 encodes a type1 transmembrane protein with a large 
extracellular region (Gally et al., 2004). LEV-10 is localized to the tips of the body wall 
muscle arms and colocalizes with LevRs and LEV-9 at the NMJ.  
LevRs are unable to cluster in animals carrying mutations in either lev-9 or lev-10, 
though surface expression levels of the receptor and functional responses to levamisole 
application remain normal.  Electrophysiological analysis shows normal responses to 
pressure-applied levamisole but large reductions in evoked responses in lev-9 mutants, 
further supporting the idea that receptors are expressed at the surface normally but are 
unable to cluster at synapses in the absence of LEV-9 and LEV-10. The localization of 
both ACR-16R and GABARs at the NMJ and cholinergic presynaptic boutons remain 
unaltered in the absence of LEV-9. These data indicate that LEV-9 and LEV-10 are 
specifically required to localize LevRs to synapses at the NMJ (Gendrel et al., 2009).   
Though genetic pathways required to cluster cholinergic receptors have been 
identified, less is known about genetic pathways underlying GABA synapse clustering 
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and localization in C. elegans.  Most of the studies conducted have focused on the role of 
presynaptic release in clustering postsynaptic GABAergic receptors. In wild type animals, 
GABA receptors form puncta along the tips of muscle arms where they cluster opposed 
to presynaptic release sites (Gally and Bessereau, 2003a). Removing GABA motor 
neuron innervation of muscle results in a loss of these puncta and a diffusion of GABAR 
in the body wall muscle cell surface (Rowland et al., 2006). This result suggests that 
presynaptic neurons provide a cue for the trafficking of GABA receptors.   This cue is not 
related to neurotransmission, as presynaptic GABA release is not required for the 
localization of UNC-49 or for the differentiation of GABA presynaptic terminals (Jin et 
al., 1999a); (Gally and Bessereau, 2003a). GABA receptor clustering remains wild type 
in the absence of cholinergic innervation and complete denervation of muscle results in 
the accumulation of receptor GFP in autophagosomes (Gally and Bessereau, 2003a).  The 
cue that stimulates GABA receptor clustering remains unknown, but some speculate that 
a secreted growth factor, an extracellular matrix molecule or other cell surface receptor in 
the presynaptic neuron fulfills this function.  
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Significance of this work 
Excitotoxicity in the nervous system 
It is widely recognized that the hyperactivation of ion channels can have 
devastating consequences for the nervous system, often resulting in cell death. Ion 
channel-mediated neuronal death is the result of the excitotoxic events that occur during 
ischemic stroke (Simon et al., 1984), and has also been observed in a variety of human 
neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) (Grosskreutz et 
al., 2010). Despite overwhelming evidence documenting the importance of excess ion 
channel activation in triggering neuronal degeneration, a mechanistic understanding of 
the downstream cellular events that lead to neuronal damage and death remains largely 
unclear.   
In this work, I developed a C. elegans model of ionotropic receptor-mediated 
excitotoxicity in motor neurons. I used this model to identify a calcium-mediated cell 
death pathway that triggered necrotic-like cell death in response to hyperactivation.  
Additionally, I showed evidence that necrotic-like death of cell bodies is genetically 
separable from the mechanisms that control destabilization of motor axons.  These 
findings provide mechanistic insights into ion-channel mediated cell death and establish a 
genetic model for further study of pathways underlying excitotoxicity.  
 
Activity-dependent mechanism instructing inhibitory network assembly and maintenance  
 The balance of excitation and inhibition within neural circuits is required for 
proper brain function.  Loss of the ability to maintain this balance leads to cases of hyper- 
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and hypo-activation within the brain that can lead to dysfunction.  Many common 
neurological diseases ranging from autism to epilepsy are thought to have an E/I balance 
component.  Though these studies establish the importance of maintaining E/I balance for 
brain function, the genetic pathways that regulate activity levels during development have 
not been completely characterized.  
Through my work, I have shown a mechanism by which excitatory drive instructs 
the patterning and strength of inhibitory motor neurons during development.  I have also 
demonstrated differential roles for excitatory drive in the developing versus the mature 
nervous system.  I observed a rapid scaling of inhibitory synapse size in response to 
changes in excitatory activity, which supports the existence of acute activity-dependent 
plasticity, a phenomenon that has not been thoroughly characterized in C. elegans.  
Exploratory experiments have linked the conserved genes nrx-1/neurexin and nlg-
1/neuroligin to this activity-dependent process providing evidence that my model can be 
used to identify genes required for synapse development and plasticity.  
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A dominant mutation in a neuronal acetylcholine receptor subunit leads 
to motor neuron degeneration in Caenorhabditis elegans 
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Abstract 
Inappropriate or excessive activation of ionotropic receptors can have dramatic 
consequences for neuronal function and, in many instances, leads to cell death.  In 
Caenorhabditis elegans, nicotinic acetylcholine receptors (nAChR) subunits are highly 
expressed in a neural circuit that controls movement.  Here, we show that heteromeric 
nAChRs containing the acr-2 subunit are diffusely localized in the processes of 
excitatory motor neurons and act to modulate motor neuron activity.  Excessive signaling 
through these receptors leads to cell-autonomous degeneration of cholinergic motor 
neurons and paralysis.  C. elegans double mutants lacking calreticulin and calnexin- two 
genes previously implicated in the cellular events leading to necrotic-like cell death (Xu 
et al., 2001a)- are resistant to nAChR-mediated toxicity and possess normal numbers of 
motor neuron cell bodies. Nonetheless, excess nAChR activation leads to progressive 
destabilization of the motor neuron processes and, ultimately, paralysis in these animals. 
Our results provide new evidence that chronic activation of ionotropic receptors can have 
devastating degenerative effects in neurons and reveal that ion channel-mediated toxicity 
may have distinct consequences in neuronal cell bodies and processes.  
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Introduction 
Roles for ionotropic receptor-mediated signaling in the nervous system extend far 
beyond a well-characterized participation in cell-cell communication at synapses. 
Ionotropic receptor activation is one of several key factors that influence cell survival in 
developing and mature nervous systems.  For example, signaling through nicotinic 
acetylcholine receptors (nAChRs) promotes the elimination of neurons is the developing 
avian autonomic nervous system {(Hruska and Nishi, 2007; Hruska et al., 2009).  In the 
mature nervous system, inappropriate or excessive ion channel activation can have 
dramatic consequences.  In mammals, hypoxic events, such as stroke, lead to excitotoxic 
cell death as a consequence of excess glutamate release and hyperexcitation of ionotropic 
glutamate receptors (iGluRs) (Sattler and Tymianski, 2001). Likewise, mutations that 
cause prolonged activation of nAChRs or iGluRs can lead to neurodegeneration and cell 
death in organisms ranging from nematodes to mammals (Treinin and Chalfie, 
1995);(Zuo et al., 1997);(Heintz and Zoghbi, 2000);(Orr-Urtreger et al., 2000);(Labarca 
et al., 2001);(Orb et al., 2004);(Miwa et al., 2006). Excess ion channel activation is also a 
contributing factor in neurodegenerative diseases. For example, the selective 
vulnerability of motor neurons to cell death in amyotrophic lateral sclerosis (ALS) is 
believed to arise, at least in part, from hyperactivation of calcium-permeable AMPA type 
iGluRs (Kwak and Weiss, 2006);(Grosskreutz et al., 2010). Interestingly, in various 
mouse models of motor neuron disease, including ALS, genetic manipulations that 
prevent the death of motor neuron cell bodies are not successful in halting disease 
progression (Sagot et al., 1995);{(Gould et al., 2006). In most cases, however, a cohesive 
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picture of the cellular events that influence the progression toward cell death as a 
consequence of ion channel hyperactivation remains unclear.  
 Ionotropic receptor signaling and its contribution to neurodegeneration can be 
dissected in details in the compact nervous system of the nematode Caenorhabditis 
elegans.  Here, we provide evidence that the non-α nAChR subunit ACR-2 contributes to 
a heteromeric receptor that is important for regulating the activity of excitatory motor 
neurons.  A pore modification in ACR-2 leads to loss of motor neurons and paralysis of 
the animal. Genetic ablation of nAChR subunits that coassemble into a heteromeric 
receptor complex with ACR-2 suppresses ACR-2(L/S) (where L/S is leucine to serine 
substitution) toxicity. In addition, C. elegans double mutants lacking two genes 
previously implicated in calcium homeostasis and necrotic cell death (crt-1/calreticulin 
and cnx-1/calnexin) are resistant to nAChR-mediated toxicity and possess normal 
numbers of motor neuron cell bodies. Nonetheless, we observe a progressive 
degeneration of the motor neuron processes that leads to paralysis in these animals. Thus, 
ion channel hyperactivation has distinct consequences for neuronal cell bodies and 
processes.  
 
Results 
acr-2 encodes a nicotinic receptor subunit expressed in cholinergic motor neurons 
 The C. elegans genome encodes 29 nAChR subunits that contribute to the 
formation of distinct classes of homopentameric and heteropentameric receptors (Jones et 
al., 2007);(Rand, 2007).  Two classes of nAChRs formed from six of these subunits are 
34
expressed in body wall muscle cells and are required for neuromuscular signaling 
(Richmond and Jorgensen, 1999);(Francis et al., 2005a);(Touroutine et al., 2005). 
Previous studies have suggested that the expression of several nicotinic acetylcholine 
receptor subunits, including the non-α subunit acr-2, is enriched in motor neurons of the 
ventral nerve cord (Hallam et al., 2000);(Cinar et al., 2005a);(Jospin et al., 2009, #12023). 
To determine which ventral cord motor neurons express acr-2, we examined transgenic 
strains that expressed GFP (Chalfie et al., 1994) under the control of acr-2 regulatory 
sequences. Expression of Pacr-2::GFP was limited to the nervous system and largely 
restricted to neurons located in the ventral nerve cord.  Expression of Pacr-2::GFP did 
not overlap with expression of a GABAergic mCherry reporter (Punc-47::mCherry), 
indicating that expression of acr-2 was limited to the cholinergic  motor neurons (DA, 
VA, DB, VB) in the ventral nerve cord of adult animals (Figure 2-1A).  To determine the 
subcellular localization of ACR-2, we generated transgenic strains that expressed a full-
length ACR-2::GFP fusion protein in which GFP was inserted in frame in the 
intracellular loop region located between transmembrane domains three and four (Figure 
2-S1).  Expression of the GFP reporter construct could be observed at all larval stages 
and in the adult.  We noted the onset of expression in late embryogenesis by the threefold 
stage (~550 min after fertilization).  In first larval stage (L1) animals, when DA and DB 
motor neurons are the sole excitatory motor neurons present, ACR-2 expression was 
clearly visible in ventral nerve cord processes. DA and DB motor neuron dendrites 
receive synaptic input in the ventral cord, and these neurons extend commissural axons to 
the dorsal cord where they form neuromuscular synapses with the dorsal musculature. In 
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adult animals, we found that the fusion protein was diffusely localized to neuronal 
processes of the dorsal and ventral nerve cords.  Out analysis suggests that ACR-2 is 
diffusely localized with enriched expression in the dendritic compartment of cholinergic 
motor neurons.  
 The locomotory control interneurons provide synaptic input to the excitatory 
motor neurons; however, the role of acetylcholine (ACh) in this signaling remains 
unclear.  To evaluate whether the locomotory control interneurons are cholinergic, we 
examined transgenic strains that co-expressed GFP under the control of regulatory 
elements for the gene encoding the ACH vesicular transporter (Punc-17::GFP) together 
with the red fluorescent protein mCherry expressed under the control of the regulatory 
elements for the nmr-1 gene (Pnmr-1::mCherry) (Figure 2-S2).  nmr-1 is expressed in 
the AVA, AVD, AVE and PVC locomotory control interneurons, as well as the RIM and 
AVG neurons (Brockie et al., 2001).  We noted no overlap in the pattern in the red and 
green fluorescent signals with the possible exception of the interneuron AVE, indicating 
that these two reporters labeled almost completely independent cell populations.  These 
data are consistent with the idea that the locomotory control interneurons are not 
primarily cholinergic.  The enriched expression of ACR-2 in the dendritic compartment 
of motor neurons may reflect the involvement of ACR-2 receptor complexes at synapses 
between AVE and cholinergic motor neurons; however, the lack of Punc-17::GFP 
expression in a majority of locomotory control interneurons and the diffuse distribution 
of ACR-2 are inconsistent with and exclusive role at synapses.  
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acr-2 mutants have motor defects 
The cholinergic motor neurons in the ventral nerve cord make synaptic contacts onto the 
body wall musculature that drives nematode locomotion.  To evaluate the contribution of 
ACR-2 to cholinergic motor neuron excitability and motor output, we obtained a strain 
carrying a deletion mutation (ok1887) in the acr-2 genomic locus.  The acr-2(ok1887) 
eliminates ~2.8kb of chromosomal DNA, including the transcriptional start, and is likely 
to be a null. Animals homozygous for the ok1887 allele are healthy and viable.  acr-
2(ok1887) mutants are not obviously uncoordinated, though closer inspection revealed a 
modest decrease in locomotion rate (Figure 2-1B).  Expression of the full length ACR-
2::GFP fusion protein in acr-2(ok1887) mutants was sufficient to restore normal 
movement.  
 The acetylcholinesterase inhibitor aldicarb has proven to be a useful tool for 
detecting alterations in neurotransmitter release from cholinergic motor neurons. To test 
whether ACR-2 receptor complexes may be important for regulating activity of the 
cholinergic motor neurons, we examined whether acr-2 mutant worms exhibit altered 
sensitivity to the paralyzing effects of aldicarb.  acr-2 mutant animals were slightly 
resistant to paralysis by aldicarb, and this effect was normalized by expression of ACR-
2::GFP (Figure 2-1C).  These data are consistent with the notion that ACR-2 plays a role 
in modulating the activity of cholinergic motor neurons but suggest that ACR-2 is bot 
absolutely required for motor neuron depolarization.  
 
Introducing a dominant mutation in ACR-2 leads to profound motor defects 
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 The second transmembrane domains of Cys-loop family ligand-gated ion channel 
subunits are well known to line the ion channel pore and play a critical role in channel 
gating. In particular, a highly conserved nonpolar residue (typically leucine) in the TM2 
region has been shown to have profound effects on receptor activation properties (Figure 
2-S3). Substitution of a polar amino acid (e.g., serine) for the leucine at this position 
produces a gain-of-function effect, resulting in increased activation and very slow 
inactivation (Revah et al., 1991);(Labarca et al., 1995).  
 We engineered the homologous leucine-to-serine point mutation into the sequence 
encoding the TM2 9’ position of an acr-2 rescuing construct to generate ACR-2(L/S) 
(Figure 2-S3).  Transgenic animals expressing and integrated ACR-2(L/S) array (ufIs25) 
were used for all subsequent analysis.  These animals are viable and have roughly normal 
brood sized; however, adult animals are smaller than their wild type counterparts (Figure 
2-2).  Moreover, we noted obvious locomotory defects in transgenic ACR-2(L/S) animals 
(Figure 2-2C). These defects were present in all larval stages as well as adult animals. 
Transgenic ACR-2(L/S) animals generated almost ten-fold fewer body bends than the 
wild type and failed to propagate the sinusoidal wave that is typical of nematode 
movement, although animals remained capable of head foraging movements. The effects 
of ACR-2(L/S) were dominant,  consistent with the notion that the phenotypes arose as a 
consequence of expression of a gain-of-function receptor. Our results suggest that motor 
output to head muscles in unaffected, while control of body wall musculature is 
dramatically impaired in these animals.  
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ACR-2(L/S)-induced motor neuron degeneration 
 Examination of the ventral nerve cord region of transgenic ACR-2(L/S) animals 
by differential interference contrast (DIC) microscopy showed that a subset of the ventral 
nerve cord neurons that normally express acr-2 swelled beyond their normal diameter 
and eventually disappeared, presumable as a result of cell death (Figures 2-3, 2-4).  
These results suggest that enhanced cholinergic signaling mediated by receptors 
incorporating ACR-2(L/S) leads to motor neuron toxicity. To characterize this in more 
detail, we examined the effects of ACR-2(L/S) expression in strains carrying fluorescent 
reporters that label populations of cholinergic neurons.  We observed only dim Pacr-
2::GFP fluorescence in the ventral nerve cord of ACR-2(L/S) animals, suggesting that 
many of the neurons labeled by this reporter were lost (data not shown). To evaluate the 
specificity of this effect for neurons that expressed acr-2, we examined a Punc-17::GFP 
reporter that is expressed in all cholinergic neurons (Figure 2-3) (Chase et al., 2004).  
While ACR-2(L/S) expression did not produce obvious differences in the number of head 
neurons labeled by Punc-17::GFP, we observed a dramatic decrease in the number of 
ventral nerve cord motor neuron cell bodies; yet, several motor neuron cell bodies 
remained present. The surviving neurons that included six VC motor neurons that do not 
normally express acr-2 and a more variable group of 10-12 additional excitatory motor 
neuron cell bodies (Figure 2-3, Figure 2-S4).  Based on the position and number of cell 
bodies and commissural processes, the additional surviving neurons included both DA 
and DB motor neurons that normally express acr-2, as well as AS motor neurons that do 
not. Similar to our observations for ACR-2(L/S)-induced paralysis, the effects of ACR-
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2(L/S) on motor neurons was dominant.  To evaluate the effects of ACR-2(L/S) on 
GABA motor neurons, we co-expressed ACR-2(L/S) together with an mCherry 
transcriptional reporter that labeled GABA neurons (Punc-47::mCherry) (Figure 2-
3C,D).  We observed that the full complement of GABA neurons was present and 
morphologically normal.  These data suggest that ACR-2(L/S) acts cell autonomously to 
promoter degeneration of motor neurons and that specific neurons are differentially 
susceptible to the effects of ACR-2(L/S) expression.  
 
Motor neuron loss occurs soon after onset of ACR-2(L/S) expression 
 As noted above, we observed clear ACR-2::GFP fluorescence in late 
embryogenesis.  We found that threefold embryos co-expressing ACR-2(L/S) with the 
Pacr-2::GFP transcriptional reporter possessed normal numbers of GFP-positive neurons, 
suggesting that ACR-2(L/S) toxicity occurred after hatch (Figure 2-S4).  To precisely 
determine the onset of motor neurons cell death, we imaged transgenic ACR-2(L/S) 
animals that co-expressed the Punc-17::GFP transcriptional reporter at various time 
points ranging from newly hatched larvae to adults (Figure 2-4).  We observed 
significant motor neuron loss in newly hatched larvae. Roughly 40% of the 16 
cholinergic motor neurons present in L1 animals were lost within 16h after hatch. During 
that transition from the first larval stage to the second larval stage (L2) the number of 
ventral nerve cord motor neurons increases substantially, with the addition of >50 motor 
neuron cell bodies (Sulston and Horvitz, 1977). In transgenic ACR-2(L/S) animals we 
observed only a slight increase in the number of cell bodies labeled by Punc-17::GFP 
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over the course of development.  Even by the time transgenic ACR-2(L/S) animals had 
clearly reached adulthood, the  number of Punc-17::GFP labeled motor neuron cell 
bodies was roughly comparable to that of a wild type L1 animal. The VC motor neurons 
do not express acr-2 and are clearly present in transgenic ACR-2(L/S) animals (Figure 2-
3, Figure 2-S5).  Therefore, the small developmental increase in the number of motor 
neuron cell bodies that we observe in transgenic ACR-2(L/S) animals likely represents 
that postembryonic addition of VC neurons.  These results suggest that the other classes 
of motor neurons that are born post embryonically and normally express acr-2 (e.g., VA, 
VB) are almost completely absent in adult transgenic ACR-2(L/S) animals.  
 
Mutations that suppress paralysis define the subunits of a neuronal AChR 
 To identify genes required for the toxic effects of transgenic ACR-2(L/S) 
expression, we conducted a forward genetic screen for suppressors of ACR-2(L/S) 
induced paralysis. We screened the F2 progeny of mutagenized hermaphrodites that 
expressed ACR-2(L/S) and selected animals that exhibited improved movement. A close 
examination of the mutants isolated from the screen showed that two phenotypic classes 
were easily distinguishable. One class of animals phenocopied strains that lack a well 
characterized heteromeric nAChR that mediates excitatory signaling at the 
neuromuscular junction (NMJ) and is a principal target of the antihelminthic drug 
levamisole (L-AChR). We found that members of this class were strongly levamisole-
resistant, and we isolated alleles of the levamisole resistance genes unc-38, unc-63, unc-
74, and unc-50 from these animals (Supplemental Table 2-S1). We also crossed 
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available strains carrying single loss-of-function mutations in known levamisole 
resistance genes with transgenic ACR-2(L/S) animals (Table 2-1). Consistent with the 
results from our forward genetic approach, loss-of-function mutations in either unc-38, 
unc-63, unc-74, or unc-50 were sufficient to suppress ACR-2(L/S) toxicity and restore 
movement (Figure 2-5A). Interestingly, we also found that unc-29, a non-α subunit 
required for L-AChR function, was not required for ACR-2(L/S)-induced paralysis. 
Likewise, acr-16, an essential subunit of homomeric nAChRs at the NMJ, was not 
required for ACR-2(L/S)-induced paralysis. unc-38 and unc-63 encode nAChR α 
subunits that are required for L-AChR function at the NMJ but are also expressed in the 
nervous system (Fleming et al., 1997); (Culetto et al., 2004); (Eimer et al., 2007). unc-50 
and unc-74 encode genes previously implicated in L-AChR maturation and are broadly 
expressed in muscles and neurons. Our analysis suggests that each of these gene products 
may contribute in a cooperative fashion to the generation of functional ACR-2(L/S) 
receptors and subsequent toxicity. 
A smaller number of animals isolated from the screen exhibited uncoordinated 
movement with deep body bends and showed normal sensitivity to the paralyzing effects 
of levamisole. We determined that the suppressor mutations in this second phenotypic 
class represented one complementation group and were X linked. Using single-nucleotide 
polymorphism mapping, we mapped one allele to the right of +8 on the X chromosome. 
The nAChR subunit gene acr-12 is located in this genomic region. Sequence analysis 
revealed four nonsense mutations and two missense mutations in the acr-12 coding 
sequence among our second class of suppressors (Figure 2-5B). We also found that a 
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deletion mutation (ok367) in the acr-12 gene suppressed paralysis in transgenic ACR-
2(L/S) animals and prevented the loss of motor neuron cell bodies. Expression of a full-
length acr-12 rescuing construct in acr-12(ok367);ACR-2(L/S) animals restored paralysis, 
verifying that acr-12 is required (Figure 2-5C,F). In contrast, we found that several other 
nAChR subunits with restricted expression to the nervous system were not required for 
ACR-2(L/S)- induced paralysis (Table 2-1). acr-12 encodes a nicotinic receptor α 
subunit that is broadly expressed in the nervous system, including many ventral cord 
motor neurons, but is not expressed in body wall muscles ((Cinar et al., 
2005b);(Gottschalk et al., 2005)). acr-12(ok367) mutants have grossly normal movement 
and show normal sensitivity to the paralyzing effects of levamisole. To test whether acr-
12 expression solely in cholinergic motor neurons is sufficient for ACR-2(L/S)-induced 
toxicity, we specifically restored expression of acr-12 to either ACh or GABA motor 
neurons of acr-12(ok367) mutants that carried the ACR-2(L/S) transgene (Figure 2-5C–
H). We found that-specific expression of the acr-12 cDNA in cholinergic motor neurons 
of transgenic acr-12(ok367);ACR-2(L/S) mutants led to ACR-2(L/S) toxicity and 
paralysis. In contrast, specific expression in GABA neurons had no effect. Our results 
indicate that acr-12 expression in cholinergic motor neurons is specifically required for 
ACR-2(L/S)-induced cell death. Furthermore, our results suggest that coassembly of 
ACR-2(L/S) into a heteromeric receptor complex with UNC-38, UNC-63, and ACR-12 is 
required to produce toxicity. 
 
ACR-2(L/S)-induced motor neuron loss is suppressed in cnx-1;crt-1 double mutants 
43
At least two mechanistically distinct types of cell death have been described. 
Programmed cell death or apoptosis is a form of cell death common in development and 
tissue homeostasis and occurs by a genetic program that is broadly conserved across 
metazoans (Danial and Korsmeyer, 2004). Necrosis generally occurs following cellular 
injury and is often characterized by swelling of the dying cell (Festjens et al., 
2006);(Golstein and Kroemer, 2007a). Our forward genetic screen did not identify genes 
previously implicated in the execution of either of these forms of cell death. To determine 
how ACR-2(L/S) expression leads to cell death, we introduced the ACR-2(L/S) transgene 
into genetic backgrounds deficient for genes essential for either apoptotic cell death or 
necrotic cell death (Figure 2-6). We found that a loss-of-function mutation in pro-
apoptotic ced-3 (Ellis and Horvitz, 1986) or a gain-of-function mutation in anti-apoptotic 
ced-9 (Hengartner et al., 1992) had no effect on ACR-2(L/S)-induced deaths. Thus, the 
programmed cell death machinery is not required for ACR-2(L/S)-induced 
neurodegeneration. 
Dysregulation of intracellular calcium levels contributes to cell death under a 
variety of circumstances, including necrotic cell death (Mattson et al., 2000);(Rao et al., 
2004);(Szydlowska and Tymianski, 2010). Calreticulin/CRT-1 and calnexin/CNX-1 are 
endoplasmic reticulum (ER) resident proteins that serve dual functions as Ca2+ binding 
proteins and molecular chaperones that facilitate glycoprotein folding (Ellgaard and 
Frickel, 2003). In mice, loss of either calnexin or calreticulin produces severe 
phenotypes: calnexin knock-out mice die within four months of birth, while knock-out of 
calreticulin results in embryonic lethality caused by defects in heart development 
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(Mesaeli et al., 1999);(Denzel et al., 2002). In C. elegans, crt-1 and cnx-1 single mutants 
are viable, and loss-of-function mutation in the crt-1 gene or RNA interference 
knockdown of cnx-1 expression suppresses several cases of ion channel-mediated cell 
death (Xu et al., 2001a). We found that the deletion mutation cnx-1(ok2234) had no 
significant effect on ACR-2(L/S)-induced cell death, whereas the deletion mutation crt-
1(ok948) partially suppressed the loss of motor neurons observed in transgenic ACR-
2(L/S) animals. Neither of these mutations led to significant locomotory improvement. 
As calnexin and calreticulin perform similar cellular functions, we generated a 
strain carrying loss-of-function mutations in both genes to test whether they may act 
redundantly in ACR-2(L/S)-induced toxicity. cnx-1;crt-1 double mutants were viable 
although smaller in size than wild-type animals, had grossly normal movement, and did 
not show obvious defects in nervous system connectivity. While ACR-2(L/S) expression 
in wild-type animals or cnx-1 and crt-1 single mutants caused paralysis across all 
developmental stages, we found that first larval stage cnx-1;crt-1 double mutants 
expressing ACR-2(L/S) were often capable of grossly normal locomotion (Figure 2-
7A,B,H). We also observed that the full complement of 16 cholinergic motor neuron cell 
bodies was present in L1 cnx-1;crt-1;ACR-2(L/S) animals, and we did not detect obvious 
defects in the connectivity of the cholinergic motor neurons (Figure 2-7C). These results 
indicate that embryonic born motor neurons developed normally and made appropriate 
synaptic contacts onto their partner muscle cells, suggesting that the combined loss of crt-
1 and cnx-1 is strongly neuroprotective against ACR-2(L/S) toxicity in L1 animals. We 
observed that adult cnx-1;crt-1 double mutants expressing ACR-2(L/S) also possessed 
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normal numbers of cholinergic motor neuron cell bodies, providing additional evidence 
that the presence of either calnexin or calreticulin is required for the cellular events that 
lead to ACR-2(L/S)-induced cell deaths (Figures 2-6F,G, 2-7D). However, larvae that 
had progressed beyond L1 and adult cnx-1;crt-1;ACR-2(L/S) animals were unable to 
propagate sinusoidal body bends and move effectively. This observation suggested that 
ACR-2(L/S) expression in cnx-1;crt-1 double mutants led to a progressive disruption of 
motor function even when motor neuron death was attenuated. 
To determine whether altered motor neuron connectivity may underlie the 
paralysis of adult cnx-1;crt-1;ACR-2(L/S) animals, we made a close examination of the 
cholinergic motor neuron processes (Figure 2-7E–G,I). We found that defects in the 
motor neuron processes of control cnx-1;crt-1 double mutants occurred only rarely 
(Figure 2-S6), and these animals exhibited grossly normal movement across all stages of 
development. In cnx-1;crt-1 double mutants that expressed ACR-2(L/S), we observed 
defasciculation of the ventral nerve cord neuronal processes (in 96% of animals scored; 
n=30), as well as defects in the morphology of commissural axons (in 75% of axons) 
(Figure 2-7). We often observed several classes of defects within individual animals and, 
in some instances, individual commissural axons contained multiple defects. The defects 
were of several types. First, we observed abnormal axon branches that often terminated in 
growth cone-like structures (54% of animals). Second, we observed ectopic sprouting 
with no clear single axonal process present (71% of animals). Finally, we observed axons 
with abnormal trajectories and wandering growth (83% of animals). These results suggest 
that the muscle targets of cholinergic motor neuron processes are not appropriately 
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innervated in adult animals. We observed that the frequency of these defects increased 
dramatically after the first larval stage (Figure 2-7I), suggesting that a progressive 
deficiency in the stabilization or maintenance of appropriate neuromuscular connectivity 
underlies the paralysis we observed in mature animals. 
To better understand the mechanisms underlying the suppression of ACR-2(L/S)-
mediated cell death in cnx-1;crt-1 animals, we directly evaluated the role of intracellular 
calcium. We found that culturing transgenic ACR-2(L/S) animals in the presence of 
dantrolene, an inhibitor of ER calcium release, or the calcium chelator EGTA (Figure 2-
8A,B) led to a modest but significant increase in the number of surviving motor neuron 
cell bodies. Similarly, we observed reduced ACR-2(L/S) toxicity in unc-68 mutants 
lacking functional ryanodine receptors (Figure 2-8C). These results provide evidence 
that intracellular calcium signaling contributes to cell death in ACR-2(L/S) animals and 
support the idea that altered intracellular calcium in cnx-1;crt-1 double mutants may 
likewise contribute to the neuroprotection we observed. To test whether altered 
expression of ACR-2(L/S) in cnx-1;crt-1 double mutants may also be a contributing 
factor, we measured levels of ACR-2::GFP fluorescence. We observed an approximately 
twofold decrease in ACR-2::GFP fluorescence in both the cell bodies and ventral nerve 
cord of cnx-1;crt-1 double mutant animals compared to wild-type animals (Figure 2-8D–
G). This result suggests that a decrease in the levels of ACR-2(L/S) in cnx-1;crt-1 
animals also contributes to the neuroprotection we observe. 
 
Discussion 
Our analysis of ACR-2-containing nicotinic receptors in C. elegans neurons has 
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revealed common features between the function of these receptors in the C. elegans 
nervous system and roles for heteromeric nAChRs in the vertebrate brain (Dani and 
Bertrand, 2007). First, heteromeric nAChRs in the mammalian brain are not primarily 
concentrated at postsynaptic sites; instead, they are more variably localized to presynaptic, 
preterminal, and nonsynaptic sites. Similarly, we find that ACR-2-containing nAChRs 
appear diffusely localized to the processes of excitatory motor neurons, suggesting that 
these receptors may function at extrasynaptic sites. Second, heteromeric brain nAChRs 
primarily function to modulate neurotransmitter release and neuronal excitability. Our 
studies of acr-2 loss-of-function mutants indicate that heteromeric nAChRs containing 
ACR-2 modulate the excitability of cholinergic motor neurons but are not absolutely 
required for motor neuron depolarization or ACh release at neuromuscular synapses. 
Third, mouse studies have shown that knock-in expression of a heteromeric brain nAChR 
subunit bearing a L/S pore modification homologous to the one we describe here causes 
dramatic neuron loss and perinatal lethality (Labarca et al., 2001). Likewise, transgenic 
expression of ACR-2(L/S) leads to cell-autonomous neurodegeneration.  
Importantly, our transgenic approach also enabled us to identify genes required 
for ACR-2(L/S) toxicity. Mutations that suppressed both the paralysis and 
neurodegeneration caused by ACR-2(L/S) expression defined the constituent subunits of 
a putative multimeric ACR-2 receptor complex as well as genes required for receptor 
trafficking and assembly. Additionally, a single gene mutation in crt-1, previously shown 
to suppress other forms of ion channel-mediated cell death in C. elegans, partially 
suppressed ACR-2(L/S) toxicity. We found that the loss of motor neurons caused by 
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ACR-2(L/S) expression was completely suppressed in adult cnx-1;crt-1 double mutants; 
yet, these animals remained paralyzed. Interestingly, suppression of ACR-2(L/S)- 
induced cell death uncovered a secondary consequence of ACR- 2(L/S) expression: the 
accumulation of morphological defects in the processes of surviving motor neurons. 
These axonal defects resemble outgrowth errors typically associated with secondary 
regrowth of axons (Knobel et al., 2001);(Hammarlund et al., 2007a). Therefore, the 
severe morphological defects we observed in adult animals may reflect inappropriate 
regrowth subsequent to destabilization. We propose that the necrotic-like cell death and 
destabilization of neuronal processes observed in our studies may represent genetically 
separable events and suggest that our transgenic approach may afford a powerful system 
to tease apart the molecular pathways that differentially contribute to these two processes. 
 
ACR-2 is part of a heteromeric nAChR in cholinergic motor neurons 
We have demonstrated that acr-2 shows restricted expression to cholinergic motor 
neurons of the ventral nerve cord and appears diffusely localized in neuronal processes. 
These results suggest that the ACR-2 receptor complex may modulate motor neuron 
excitability by mediating signaling at extrasynaptic sites. Consistent with this notion, acr-
2 loss-of-function mutants are not grossly uncoordinated and show only modest 
resistance to the paralyzing effects of the ACh esterase inhibitor aldicarb. 
Aldicarb-induced paralysis arises as a consequence of the prolonged action of ACh in the 
synaptic cleft; our analysis suggests that ACh release from motor neurons is decreased in 
acr-2 mutants. Another recent study reached a similar conclusion based on 
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electrophysiological analysis of acr-2 loss-of-function mutants (Jospin et al., 2009). We 
also show that the locomotory control interneurons (with the possible exception of 
AVE)—the major source of synaptic inputs to excitatory motor neurons—do not express 
a reporter that labels cholinergic neurons, suggesting these neurons are unlikely to be 
cholinergic. Therefore, what is the source of ACh for activation of ACR-2 receptor 
complexes? The presynaptic ACh release sites of en passant neuromuscular synapses are 
highly intermingled and densely packed because of the intercalation of neuronal 
processes in the nerve cord. Thus, one possibility is that these receptors are activated by 
spillover of ACh from release sites at nearby neuromuscular synapses. 
Our genetic analysis showed that mutations in three genes encoding AChR 
subunits can suppress the neurotoxic effects associated with expression of pore-modified 
ACR-2(L/S) receptors. unc-38 and unc-63 are highly expressed in ventral cord motor 
neurons and also contribute to a heteromeric receptor complex that mediates excitatory 
neurotransmission at the NMJ (Fleming et al., 1997);(Culetto et al., 2004). acr-12 is 
broadly expressed in the nervous system but is not expressed in body wall muscles (Cinar 
et al., 2005b; Gottschalk et al., 2005). Our data are consistent with the notion that UNC-
38, UNC-63, and ACR-12 coassemble with the ACR-2 subunit [either native ACR-2 or 
transgenic ACR-2(L/S)] to form heteromeric nAChRs in cholinergic motor neurons 
(Jospin et al., 2009). Loss-of-function mutations in any of these genes impair assembly or 
function of ACR-2 receptor complexes in cholinergic motor neurons and suppress ACR-
2(L/S)-induced cell death. Several pieces of evidence support this idea. First, mutations 
in unc-29 and acr-16—genes that contribute to nAChRs at the NMJ and are essential for 
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normal excitatory neurotransmission at neuromuscular synapses (Richmond and 
Jorgensen, 1999);(Francis et al., 2005a);(Touroutine et al., 2005)—do not suppress ACR-
2(L/S) neurotoxicity, indicating that reduced excitatory neuromuscular signaling alone is 
insufficient to suppress ACR-2(L/S)-induced toxicity. Second, specific expression of acr-
12 in the cholinergic motor neurons of transgenic acr-12 mutants expressing ACR-2(L/S) 
was sufficient to produce paralysis, whereas specific expression of acr-12 in other neuron 
classes was without effect. Third, it has recently been shown that coexpression of five 
subunits—ACR-2, ACR-12, UNC-38, UNC-63, and ACR-3— was required for 
reconstitution of ACR-2 receptor complexes in a heterologous system (Jospin et al., 
2009). 
 
Pore-modified ACR-2(L/S) receptors cause ion channel-mediated neurotoxicity 
We have shown that expression of the ACR-2(L/S) transgene leads to 
degeneration of the cholinergic motor neurons and paralysis, reinforcing the importance 
of these neurons in generating sinusoidal movement. The GABA motor neurons develop 
normally even in the absence of ACh motor neurons, their major source of synaptic input, 
indicating that the toxic effects of ACR-2(L/S) expression are cell autonomous. We 
found that mutations in genes that are essential for the formation of functional ACR-2 
heteromeric receptors suppress this effect, consistent with the idea that excessive receptor 
activity leads to neurodegeneration. Our results suggest that the level of receptor activity 
is a critical determinant in the progression toward necrotic cell death. Consistent with this 
idea, a less severe gain-of-function acr-2 allele leads to cellular hyperexcitability without 
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obvious loss of motor neurons (Jospin et al., 2009). Interestingly, mouse studies using 
knock-in expression of similarly pore-modified heteromeric nAChR subunits have 
reported qualitatively similar degeneration as a consequence of excess receptor activation 
(Orr-Urtreger et al., 2000);(Labarca et al., 2001);(Orb et al., 2004). Knock-out of Lynx1, 
an endogenous negative regulator of nAChR function in the mouse brain, also leads to a 
similar form of vacuolating degeneration that is exacerbated by nicotine (Miwa et al., 
2006). 
Release of calcium from internal stores plays a major a role in many forms of cell 
death, including some forms of ion channel mediated toxicity. Pharmacological or 
genetic manipulation of intracellular calcium levels led to a modest suppression of ACR-
2(L/S)-induced toxicity, providing evidence that calcium plays an important role. 
However, ACR-2::GFP fluorescence was decreased substantially in cnx-1;crt-1 double 
mutants, suggesting that a reduction in protein levels of the toxic transgene also 
contributes to suppression of cell death. Similar to the case for ACR-2(L/S) expression, 
cell death because of a gain-of-function mutation in another C. elegans nAChR subunit, 
DEG-3, is not suppressed by a single gene mutation in crt-1 (Treinin and Chalfie, 
1995);(Xu et al., 2001a);(Syntichaki et al., 2002). Our findings suggest that a requirement 
for genes additional to crt-1 may be a common feature of nAChR-mediated neuronal 
death that is distinct from cell death caused by hyperactive Na+ channels such as MEC-
4(d). 
In mouse models of motor neuron disease, such as progressive motor 
neuronopathy (pmn) or the transgenic SOD1 G93A model of amyotrophic lateral 
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sclerosis, apoptosis of neuronal cell bodies was blocked by expression of the anti-
apoptotic Bcl-2 gene or knock-out of the pro-apoptotic Bax gene (Sagot et al., 
1995);(Gould et al., 2006). In each case, degeneration of the neuronal processes 
continued unimpeded and disease progression was unaffected. ACR-2(L/S)-induced cell 
death clearly occurs independently of the apoptotic pathway. However, it is interesting to 
note that we also observe a progressive destabilization of the motor neuron processes that 
leads to paralysis even under conditions when death of the cell body is attenuated. 
Therefore, NMJ denervation that occurs independently of the death of neuronal cell 
bodies is the dominant feature shared across each of these cases. In the future, it will be 
interesting to uncover the molecular events leading to degeneration of the neuronal 
processes and determine whether elements of the degenerative process are conserved 
across these diverse models. 
 
Materials and Methods 
Molecular biology 
AChR subunit constructs. The full-length ACR-2::GFP transgene (pDM1232) was 
generated by introducing the green fluorescent protein (GFP) coding sequence in-frame 
into the sequence of an acr-2 genomic fragment (-3353 to +7776 bp relative to the 
translational start site) encoding the intracellular loop between transmembrane domains 
TM3 and TM4. The full-length ACR-2(L/S) construct (pBB9) was generated by PCR-
based site directed mutagenesis using mutant primers and pDM1232 as the template. The 
Pacr-2::ACR-12 cDNA (pHP3) and Punc-47::ACR-12 cDNA (pBB25) constructs were 
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generated by amplifying the acr-12 cDNA from the expressed sequence tag yk1093d12 
(gift from Yuji Kohara, National Institute of Genetics, Mishima, Japan) using sequence-
specific primers designed to the start and stop of acr-12 and subcloning it into the 
NheI/SacI sites of a plasmid containing an ~3.3 kb promoter for the acr-2 gene or into a 
plasmid containing a 1.3 kb promoter for the unc-47 gene.  
Transcriptional reporters. The Punc-47::mCherry construct (pPRB5) was generated by 
subcloning an AgeI/AatII fragment that contained the full-length mCherry coding 
sequence into a vector containing a 1.3 kb promoter for the unc-47 gene. The Pacr-
2::GFP (pPRB19) construct was generated by subcloning an AatII/BamHI fragment that 
contained an ~3.3 kb promoter for the acr-2 gene into a vector containing the GFP coding 
sequence. 
 
C. elegans strains 
C. elegans strains were grown on nematode growth medium (NGM) plates with 
the OP50 strain of Escherichia coli at 22°C using standard laboratory procedures. Wild-
type animals are the N2 Bristol strain. All transgenic strains were obtained by 
microinjection of plasmid DNA into the germ line and data presented are from a single 
representative transgenic line unless noted otherwise. In all cases, lin-15(n765ts) mutants 
were injected with the lin-15 rescuing plasmid (pL15EK; 30 ng/µl) and one or more of 
the following plasmids (30 ng/µl): pBB9, pBB25, pDM1232, pHP3, pPRB4, pPRB5, 
pPRB14, pPRB19. Multiple independent extragenic lines were obtained for each 
transgenic strain. Stably integrated lines were generated as necessary by x-ray integration 
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and outcrossed at least four times to wild type. The transgenic strain expressing the 
integrated ACR-2(L/S) transgene (ufIs25) was outcrossed 10 times to wild type. The 
following strains were used in this study: RB1559 acr-2(ok1887), IZ421 acr-12(ok367), 
RB2071 ced-3(ok2734), VC1801 cnx-1(ok2234), RB1021 crt-1(ok948), IZ74 unc-29(x29), 
CB904 unc-38(e264), CB306 unc-50(e306 ), VC731 unc-63(ok1075), CB883 unc-
74(e883), IZ380 ufIs31, IZ814 ufIs25, IZ625 ufIs25;ufIs31, IZ790 ufIs49, IZ627 ufIs42, 
LX949 vsIs48, IZ924 ufIs25;vsIs48, IZ950 ced-3(ok2734); ufIs25;vsIs48, IZ877 cnx-
1(ok2234);ufIs25;vsIs48, IZ926 crt-1(ok948);ufIs25;vsIs48, IZ976 crt-1(ok948);cnx-
1(ok2234);ufIs25;vsIs48, IZ971 crt-1(ok948);cnx-1(ok2234);vsIs48, IZ927 crt-
1(ok948);cnx-1(ok2234);ufIs42, IZ787 unc-29(x29);ufIs25, IZ928 acr-3(ok2049);ufIs265, 
IZ929 acr-5(ok180);ufIs25, IZ930 acr-9(ok933);ufIs25, IZ931 acr-19(ok967); ufIs25, 
IZ932 acr-23(ok2840);ufIs25,IZ446 unc-38(e264 );ufIs25, IZ659 unc-50(e306);ufIs25, 
IZ921 unc-63(ok1075);ufIs25, IZ490 unc-68(e540);ufIs25, IZ604 unc-74(e883);ufIs25, 
IZ673 acr-12(ok367);ufIs25;ufEx148,IZ937 acr-12(ok367);ufIs25;ufIs60, IZ861 acr-
12(ok367);ufIs25;ufEx191. 
 
Genetic screen and identification of suppressors ofACR-2(L/S)-induced paralysis 
Paralyzed animals expressing the integrated ACR-2(L/S) array (ufIs25) were 
mutagenized with 50 mM ethyl methanesulfonate ((Brenner, 1974a)). Young adult F2 
progeny of  ~20,000 mutagenized animals were washed twice with M9 and transferred to 
fresh plates. After allowing time for the animals to disperse, moving animals were picked 
to single plates. Eighty-one candidate suppressors were isolated. A secondary screen 
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showed that fifty-one of these were resistant to the paralyzing effects of levamisole. For 
genetic complementation tests, males carrying a mutation in candidate levamisole-
resistance genes were crossed with hermaphrodites carrying the ACR-2(L/S) transgene 
and a suppressor mutation. F1 progeny were scored for paralysis. A cross was performed 
in parallel using N2 males to identify X-linked suppressor mutations and determine 
dominance/recessivity. The mapping of acr-12 alleles was performed in the presence of 
the ACR-2(L/S) transgene. A strain carrying the integrated ACR-2(L/S) transgene 
(ufIs25) on linkage group I was backcrossed 7x to the CB4856 Hawaiian strain. acr-12 
alleles were mapped to a region the right of  +8 on the X chromosome using the SNP 
mapping procedure described as previously ((Wicks et al., 2001); (Davis et al., 2005)). 
 
Behavioral assays 
All behavioral analysis was performed with young adult animals (24 hpost-L4) at room 
temperature (22°C–24°C); different genotypes were scored in parallel, with the 
researcher blinded to the genotype. 
Aldicarb and levamisole assays. Staged populations of adult animals 
(~10) were transferred to NGM plates containing 1mM aldicarb (Chem-Service), and 
movement was assessed every 15 min for 2 h. Data represent the mean  ±SEM of at least 
four assays. For levamisole assays, staged populations of adult animals were scored for 
paralysis after 120 min on plates containing 200 µM levamisole. 
Body bend analysis. Body bends were scored on unseeded NGM agar. Animals were 
transferred from their culture plate to an unseeded plate and allowed to crawl away from 
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any food that might have been transferred. The animals were then gently transferred 
without food to another unseeded plate and allowed to recover for 1 min. After the 
recovery period, the animals were filmed for 5 min using Imaging Source DMK21F04 
FireWire camera and iMovie software. 
 
Microscopy 
Confocal microscopy was performed using a Zeiss Axioskop 2 microscope system and 
LSM Pascal 5 imaging software (Zeiss). Images were processed using ImageJ software 
(open source). Epifluorescent imaging was performed using a Zeiss Axioimager M1 
microscope and Axiovision software (Zeiss). Movies and still images for behavioral 
analyses were obtained using an Olympus SZ61 upright microscope equipped with a 
FireWire camera (Imaging Source). For the developmental timeline, synchronized 
populations were obtained by bleaching gravid animals on NGM plates seeded with 
OP50. The resulting progeny were allowed to mature at room temperature. Animals were 
imaged at 16, 28, 38, and 48 h after bleaching using wide-field epifluorescent microscopy, 
and the number of surviving cell bodies was counted manually with the researcher 
blinded to genotype. 
  
57
Figure 2-1: acr-2 is expressed in cholinergic motor neurons and modulates motor 
neuron activity.  
A. Confocal image of the posterior ventral nerve cord of an adult animal coexpressing a 
GABA-specific marker (Punc-47::mCherry) and an ACR-2 specific marker (Pacr-
2::GFP). No overlap is observed between GFP-expressing and mCherry-expressing 
neurons. The animal is orientated with the posterior (tail) on the right.  B. Quantification 
of movement on a food-free agar plate.  Average number of body bends per minute for 
wild type, acr-2(ok1887) mutants, and acr-2(ok1887) mutants expressing full-length 
ACR-2::GFP (ufIs42) over a 5 minute period are shown.  Data represents mean ±SEM of 
at least 10 trials; **p,0.01 compared to wild type.  C. Time course of paralysis in the 
presence of the cholinesterase inhibitor aldicarb (1mM) for wild type, acr-2(ok1887) 
mutants and acr-2(ok1887) mutants expressing full-length ACR-2::GFP (ufIs42). The 
percentage of immobilized animals calculated every 15 minutes over a time course of 2hr 
is shown.  Each data point represents the mean ±SEM for at least four trials. *p,0.001, 
two-way ANOVA.  
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Figure 2-2: Transgenic animals expressing the dominant ACR-2(L/S) transgene are 
severely uncoordinated.  
A, B. Still image of a wild type animal (A) and a transgenic animal expressing the ACR-
2(L/S) transgene (B).  Not the coiled posture and reduced size that occurs as a result of 
ACR-2(L/S) expression.  C. Quantification of the movement on a food-free agar plate.  
Average number of body bends per minute for wild type, acr-2(ok1887) mutants, and 
transgenic animals expressing full-length ACR-2(L/S) (ufIs25) counted over a 5 min 
period are shown.  Data represents the mean ±SEM of at least 10 trials; *p<0.02, 
**p<0.0001.  
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Figure 2-3: Transgenic expression of ACR-2(L/S) leads to a loss of cholinergic motor 
neurons.  
A, A1. DIC images of an adult wild type animal (A) and an adult transgenic animal 
expressing ACR-2(L/S) (A1). Triangles denote lesions observed along the ventral nerve 
cord of transgenic animals expressing ACR-2(L/S).  Images show a region directly 
posterior to the vulva and are oriented with the ventral surface facing up and the anterior 
of the animal to the left.  B,B1: Wide-field epifluorescent images of a transgenic animal 
expressing the cholinergic motor neuron marker Punc-17::GFP (vsIs48) (B) and a 
transgenic animal coexpressing ACR-2(L/S) with Punc-17::GFP (B1). The few Punc-
17::GFP-labeled motor neurons that remain in transgenic ACR-2(L/S) animals include 
the six VCs (indicated) and a more variable group of ~10-12 neurons (arrowheads). C. 
C1: Wide-field epifluorescent images of a transgenic animal expressing Punc-
47::mCherry (ufIs53) (C) and a transgenic animal coexpressing Punc-47::mCherry with 
ACR-2(L/S) (C1). The full complement of Punc-47::mCherry-labeled motor neurons 
remains in transgenic ACR-2(L/S) animals and is indicated.  D. Quantification of the 
total number of motor neurons in wild type (grey) and ACR-2(L/S) animals (black); 
*p<0.01 student t-test. For all images, animals are positioned with the head on the left 
side of the image.  
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Figure 2-4: ACR-2(L/S)-induced motor neuron cell death is initiated before hatch.   
A, B: Wide-field epifluorescent images of wild type (A) and transgenic ACR-2(L/S) 
animals (B) expressing Punc-17::GFP images 16, 28, 38 and 48 hours after bleach 
synchronization of embryos.  C, D: Confocal images of first larval stage wild type (C) 
and transgenic ACR-2(L/S) animals (D) expressing Punc-17::GFP. Swollen or dying 
neuronal cell bodies are indicated (arrowheads). E. Quantification of the average number 
of cell bodies at the time points indicated for wild type (black bars) and transgenic ACR-
2(L/S) animals (gray bars).  Bars represent the mean ±SEM for 5-8 animals at each time 
point.  
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Figure 2-5: Mutations in nicotinic acetylcholine receptor subunits suppress ACR-
2(L/S)-induced paralysis.  
A. Quantification of the average number of body bends per minute for wild type animals, 
acr-12(ok367), unc-63(ok1075), unc-38(e246), unc-74(e883) and unc-50(e306) mutants 
in the absence (grey bars) presence (black bars) of the ACR-2(L/S) transgene.  Animals 
were placed on a food-free agar plate, and the average number of body bends per minute 
was quantified over a five minute period. Data represent the mean ±SEM of at least ten 
animals for each genotype. B. Schematic of the membrane topology of ACR-12 with the 
approximate location, allele names and molecular nature of loss-of-function mutations 
that suppress ACR-2(L/S) toxicity indicated. C. Quantification of the average number of 
body bends per minute for the following genotypes: wild type, acr-12(ok367), transgenic 
ACR-2(L/S), acr-12 mutants expressing ACR-2(L/S), acr-12 mutants expressing ACR-
2(L/S) together with an extrachromosomal array containing Punc-47::ACR-12 and acr-
12 mutants expressing ACR-2(L/S) together with an extrachromosomal array containing 
Pacr-2::ACR-12.  Data represent the mean ±SEM for 5-10 animals. D-H: Still images of 
adult animals on NGM plates without food for the genotypes indicated.  “GABA” and 
“ACh” refer to specific expression of the acr-12 cDNA in GABAergic or cholinergic 
neurons using the unc-47 or acr-2 promoters, respectively.  
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Figure 2-6: ACR-2(L/S)-mediated motor neuron loss is completely prevented in 
animals doubly mutant in calnexin and calreticulin.  
A-F:  Representative wide-field images of Punc-17::GFP fluorescence in the ventral 
nerve cord of adult animals for the genotypes indicated.  For each image the head is 
orientated to the left. The alleles used were ced-3(ok2734), cnx-1(ok2234), and crt-
1(ok948). G. Quantification of the average number of Punc-17::GFP labeled cell bodies 
present in the ventral nerve cord for the genotypes indicated. Data represents the mean 
±SEM for at least ten animals per genotype. *p<0.01, **p<0.001, compared to transgenic 
ACR-2(L/S) animals.  
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Figure 2-7: Progressive destabilization of motor neuron processes in cnx-1;crt-1; 
ACR-2(L/S) animals.  
A,B: Frames showing the movement of L1 transgenic ACR-2(L/S) animals (A) or cnx-
1;crt-1;ACR-2(L/S) animals (B) 30s (t=0), 60s (+30), or 90 s (+60) after transfer to an 
agar plate.  The black arrow marks the starting positions of the worms in each frame.  
The transgenic ACR-2(L/S) animal does not move from where it was placed on the plate.  
The dashed line shows the movement path of the L1 cnx-1;crt-1;ACR-2(L/S) animals 
over the course of 60 s.  The additional tracks on the plate show the path of the animals in 
an ~30 s period before imaging began.  C,D: Confocal images of a first larval stage (C) 
or adult cnx-1;crt-1;ACR-2(L/S) animals (D) expressing Punc-17::GFP.  Images show Z-
projections of 15 confocal planes (0.5 µM/slice) (C) or 16 confocal planes (0.5 µM/slice) 
(D). Arrows (D) indicate positions of commissures.  Dashed box (D) indicates area with 
multiple neuronal defects. E-G: Confocal images of cnx-1;crt-1;ACR-2(L/S) animals 
taken at hatch (E), 24 h post hatch (F), and adulthood (G). In each case, a region 
immediately posterior to the vulva was images and the ventral nerve cord is positioned at 
the top. Arrows indicate commissural processes; arrowheads indicate the ventral nerve 
cord. Images show Z-projections of 12 confocal planes (E), 23 confocal planes (F) or 33 
confocal planes (G) (0.5 µM/slice). Scale bars represent 10µM. H: Quantification of 
percentage of animals moving at hatch in ACR-2(L/S) and cnx-1;crt-1;ACR-2(L/S) 
animals. Data represent the mean number of animals ±SEM making more than two 
consecutive body bends during a 3 min period. I: Quantification of the percentage of cnx-
1;crt-1 and cnx-1;crt-1;ACR-2(L/S) animals with defective neuronal process morphology. 
70
Observed defects include defasciculation of the ventral nerve cord, wandering 
commissural processes or ectopic branching.  
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Figure 2-8: Perturbation of intracellular calcium and reduced ACR-2::GFP levels in 
cnx-1;crt-1 double mutants suggest dual mechanisms for cell death suppression.  
A-C: Quantification of the average number of Punc-17::GFP-labeled cell bodies present 
in the ventral nerve cord in adult animals treated with dantrolene (A), L1 animals treated 
with EGTA (B) and adult unc-68(e540) mutants animals (C). Data represent the mean 
±SEM for at least eight animals. **p<0.01, ***p<0.001, compared to untreated ACR-
2(L/S) animals. D,E: Confocal images of adult wild type (D) or cnx-1;crt-1 (E) animals 
expressing ACR-2::GFP. Images are taken immediately posterior to the vulva and show 
Z-projections of seven confocal planes (0.5µM/slice). F,G: Quantification of 
fluorescence levels in cell bodies (F) and ventral nerve cord processes (G) of wild type 
and ACR-2(L/S) animals transgenically expressing ACR-2::GFP. Data represent the 
mean ±SEM for at least 10 animals/genotype, compared to ACR-2(L/S) animals.  
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Gene ACR-2(L/S) Suppression Description 
acr-2(ok1887) - nAChR non-α subunit 
acr-3(ok2049) - nAChR non-α subunit 
acr-5(ok180) - nAChR α subunit 
acr-9(ok933) - nAChR non-α subunit 
acr-12(ok367) + nAChR α subunit 
acr-14(ok1155) - nAChR α subunit 
acr-15(ok1214) - nAChR α subunit 
acr-16(ok789) - nAChR α subunit 
acr-19(ok967) - nAChR α subunit 
acr-23(ok2840) - nAChR α subunit 
unc-63(x37) + nAChR α subunit 
unc-38(e264) + nAChR α subunit 
unc-29(x29) - nAChR non-α subunit 
unc-50(e306) + Golgi integral membrane protein 
unc-74(e883) + Function Unknown 
 
Table 2-1: Several nAChR subunits are required for ACR-2(L/S)-induced paralysis.  
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Figure 2-S1: Expression of the non-alpha nAChR subunit ACR-2. 
A: Schematic depicting morphology of cholinergic DA and DB motor neurons in an L1 
animal. Wide-field epifluorescent projection images of the ventral (green) and dorsal 
(blue) nerve cords in L1 animals expressing integrated arrays containing either the 
transcriptional reporter Pacr-2::GFP (ufIs49, top), full-length Pacr-2::ACR-2::GFP 
(ufIs42, middle) or a presynaptic marker (Punc-4::SNB-1::GFP, lower). Pacr-2::GFP 
fluorescence is present in both ventral and dorsal nerve cords. Expression of the synaptic 
vesicle marker synaptobrevin (SNB-1::GFP) is limited to axons of the dorsal nerve cord. 
ACR-2::GFP fluorescence is limited to dendrites in the ventral nerve cord. B: Projection 
of a confocal stack showing the dorsal and ventral nerve cords of an adult animal 
expressing full-length ACR-2::GFP. C: Confocal image of ventral nerve cord showing 
diffuse ACR-2::GFP fluorescence. D: Schematic of ACR-2 membrane topology and site 
of GFP insertion. 
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Figure 2-S2: C. elegans command interneurons do not express Punc-17::GFP. 
A-C: Single confocal images of an animal co-expressing an integrated array (vsIs48) 
containing the cholinergic neuron marker Punc-17::GFP together with an 
extrachromosomal array (ufEx158) containing Pnmr-1::mCherry. D: A confocal 
projection showing the relative positions of neuronal cell bodies expressing Punc- 
17::GFP and Pnmr-1::mCherry in the head of the worm. Neurons expressing mCherry 
are indicated. Only a single AVA neuron expresses mCherry due to mosaic expression of 
the array. 
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Figure 2-S3: Sequence features of ACR-2. 
A: Amino acid sequence of ACR-2. Predicted signal sequence (dashed box), 
transmembrane domains (underline), cys-loop (gray), gain-of-function mutation (box), 
and site of GFP insertion (asterisks) are indicated. B: Alignment of the second 
transmembrane domain of ACR-2 and various mammalian non-alpha subunits. The site 
of the 9’ leucine to serine gain-of-function mutation is indicated (box). 
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Figure 2-S4: Wild type and ACR-2(L/S) animals have the same number of acr-2 
expressing cells at the 3-fold embryo stage. 
A,B: Confocal images of wild type (A) and ACR-2(L/S) (B) 3-fold embryos expressing 
an integrated array containing Pacr-2::GFP (ufIs49). Images represent Z-projections of 
23 slices (0.5 µm/slice). C: Quantification of the average number of 
Pacr-2::GFP labeled cell bodies present in wild type and ACR-2(L/S) 3-fold embryos. 
Data represents the mean ± SEM of at least ten animals per genotype. 
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Figure 2-S5: The VC neurons remain present in transgenic ACR-2(L/S) animals. 
Confocal images of wild type (A) and ACR-2(L/S) (B) animals expressing an integrated 
array (ufIs26) that contains Punc-4::mCherry. 
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Figure 2-S6: Motor neuron processes are irregular in cnx-1;crt-1 double mutants 
expressing transgenic ACR-2(L/S). 
A,B: Confocal images of commissural processes and ventral nerve cord processes in cnx-
1;crt-1 double mutants (A) and cnx-1;crt-1 double mutants expressing the ACR-2(L/S) 
transgene (B). Arrowheads show normally fasciculated ventral nerve cord in cnx- 
1;crt-1 double mutants (A) and defasciculation in cnx-1;crt-1;ACR-2(L/S) animals (B). 
Arrows show normal commissural process in (A) and ectopic sprouting in (B). In each 
case, a region immediately posterior of the vulva was imaged and the ventral nerve cord 
is positioned at the bottom. Images show Z-projections of 34 confocal planes (A) or 33 
confocal planes (B) (0.5 µm/slice). For all fluorescent imaging, animals are expressing an 
integrated Punc-17::GFP transgene (vsIs48). C: Quantification of the percentage of 
irregular commissural processes in wild type (15 commissures from 5 animals), 
transgenic ACR-2(L/S) (39 commissures from 10 animals), cnx-1;crt-1 (75 commissures 
from 19 animals) and cnx-1;crt-1;ACR-2(L/S) (93 commissures from 17 animals). Since 
Punc-17::GFP also labels AS motor neurons that project commissural axons and do not 
express acr-2, the percentage of axonal defects in ACR-2(L/S) expressing neurons is 
likely higher. 
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Supplemental Table 2-1: Suppressors of ACR-2(L/S) induced paralysis isolated 
from a forward genetic screen. 
 
  
Isolation 
number 
 
Allele 
% Paralyzed* 
(levamisole) 
 
Gene 
 Wild type 90±3  
 ok367 94±4 acr-12 
 e264 3±3 unc-38 
 e883 0 unc-74 
 ok1075 3±2 unc-63 
1 uf61 5±5 n.d. 
2 uf62 0 unc-38 
3 uf63 0 n.d. 
4 uf64 35±5 n.d. 
5 uf65 95±5 acr-12 
6 uf66 90±4 acr-12 
7 uf67 0 unc-38 
8 uf68 0 n.d. 
9 uf69 15±5 n.d. 
10 uf71 0 n.d. 
11 uf72 5±5 unc-74 
12 uf73 n.d. n.d. 
13 uf74 5±5 n.d. 
14 uf75 0 n.d. 
15 uf76 5±5 n.d. 
16 uf77 95±5 acr-12 
17 uf78 0 n.d. 
18 uf79 5±5 unc-63 
19 uf80 70±10 acr-12 
20 uf81 8±5 n.d. 
21 uf82 0 n.d. 
22 uf84 0 n.d. 
23 uf85 100 acr-12 
24 uf86 3±3 unc-50 
25 uf87 0 n.d. 
26 uf88 10 n.d. 
27 uf90 3±3 n.d. 
28 uf91 98±3 acr-12 
29 uf92 85±5 acr-12 
30 uf77 93±5 acr-12 
31 uf94 78±6 acr-12 
32 uf95 100 acr-12 
33 uf96 0 n.d. 
34 uf77 45±5 acr-12 
35 uf98 0 n.d. 
36 uf99 0 n.d. 
37 uf101 5±5 n.d. 
38 uf103 0 n.d. 
39 uf106 5±5 n.d. 
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CHAPTER III 
 
Excitatory neurons sculpt inhibitory synaptic connections in the  
C. elegans motor circuit.  
 
Belinda Barbagallo, Denis Turutin and Michael M. Francis 
 
 
 
Contribution Summary 
The following work was carried out in the lab of Dr. Michael M. Francis at the 
University of Massachusetts Medical School. Denis Turutin carried out the 
electrophysiology experiments and data analysis. Michael Francis supported the project 
by discussing experimental design, providing advice on data analysis and co-writing the 
paper.  I designed the experiments, analyzed data and co-wrote the paper.  
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Abstract 
Neuronal activity is a major driving force behind the development and 
maintenance of synapses within neural circuits.  In this study, we use the motor circuit of 
the nematode Caenorhabditis elegans as a model for circuit development.  We find that 
when neural circuits develop in the absence of excitatory drive there is a net increase in 
inhibitory signaling onto postsynaptic cells.  This increase in signaling is reflected in an 
increase in the size of both presynaptic release sites and postsynaptic receptors.  This 
change in circuit function occurs only after loss of excitatory, but not inhibitory function 
suggesting that excitatory neurons act as master regulators of circuit functional properties.  
Global reductions in activity are insufficient to alter inhibitory synapse patterning, though 
specifically disrupting excitatory drive onto GABA neurons leads to altered inhibitory 
synapses.  Loss of cholinergic function specifically during development leads to 
irreversible changes in inhibitory synapse development suggesting that an activity-
dependent critical period occurs to pattern inhibitory synapses.  Loss of excitatory drive 
in the established nervous system leads to scaling of inhibitory synapses suggesting that 
homeostatic mechanisms act in the adult nervous system to maintain circuit activity 
levels.  
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Introduction 
Neurons in the brain are organized into neural circuits that work together to 
control specific functions.  The regulation of brain function requires the appropriate 
balance of excitation and inhibition (E/I balance) within these circuits during 
developmental time windows, termed critical periods, during which synaptic connections 
are specified. The number of synapses formed, as well as the maturation of synaptic 
fields, is directly tied to circuit activity levels, highlighting the importance of regulating 
E/I balance during development (Katz and Shatz, 1996);(Moody and Bosma, 
2005);(Blankenship and Feller, 2010); (Dehorter et al., 2012); (Feldt et al., 2011).  
Shifting of E/I balance beyond the acceptable functional range can lead to hyper and 
hypo excitable states within neural circuits resulting in misregulated circuit activity.  
Many studies have identified E/I balance dysfunction components in neurological 
disorders ranging from schizophrenia to autism, though the mechanism regulating 
activity have not been fully described (Wassef et al., 2003);  (Rubenstein and Merzenich, 
2003);(Kehrer et al., 2008);(Gatto and Broadie, 2010).   
E/I balance also plays a critical role in the mature nervous system. Once networks 
are established, neural circuits must be able to adapt to changes in activity levels and 
maintain circuit output within a functional range. This is achieved through the activation 
of negative feedback mechanisms that are able to adjust synaptic strengths and maintain 
the balance of activity in a process termed homeostatic plasticity (Reviewed in (Pozo and 
Goda, 2010)). To date, a majority of the studies investigating mechanisms of homeostatic 
plasticity have been carried out in cell culture systems and show synaptic scaling in 
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response to modulation in circuit activity (Turrigiano et al., 1998).  More recent studies 
have shown that these mechanisms are more complex than originally though, with in vivo 
studies showing non-uniform scaling of synapses, suggesting that not all neuron types are 
equally affected by changes in activity levels (Cingolani and Goda, 2008); (Echegoyen et 
al., 2007); (Goel and Lee, 2007).  The complexities of circuit development highlight the 
need to better understand the mechanisms of activity-dependent circuit development and 
homeostatic mechanisms in intact neural networks.  
Here we investigate the role of E/I balance in the development and maintenance 
of inhibitory synaptic fields. Using electrophysiological and genetic approaches in the C. 
elegans motor circuit, we have shown that the loss of excitatory input throughout 
development leads to increased inhibitory signaling in the adult nervous system.  This 
increased signaling is reflected as an enlargement of both GABA presynaptic release sites 
and postsynaptic receptor clusters, suggesting that loss of excitatory drive leads to 
increased GABA synaptic efficacy.  Global reduction of neurotransmission is insufficient 
to reproduce this enhanced inhibitory phenotype, while selective disruption of cholinergic 
release onto GABA neurons resulted in altered GABA synapse size and patterning.  
We also show that ACh release is required during a developmental critical period 
to establish appropriate patterning of GABA synapses.  In the adult nervous system, loss 
of ACh release leads to compensatory scaling of GABA synapse size, suggesting that 
homeostatic mechanisms are in place to modulate activity within the mature motor circuit.  
Taken together, our results support a model where ACh release plays a duel role in 
regulating inhibitory synapse function. During development, ACh instructs GABA 
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synapse patterning while in the mature circuit, ACh levels trigger compensatory 
mechanisms that scale inhibitory synapses to maintain E/I balance in the circuit.  
 
Results 
Reduced cholinergic innervation alters inhibitory transmission 
 In order to investigate the role of excitatory signaling in shaping neural circuit 
connectivity and function, our studies focused on the anatomically well-defined C. 
elegans motor circuit. In this system, body wall muscles receive synaptic inputs from 
both excitatory and inhibitory motor neurons and the balance of this excitatory and 
inhibitory signaling shapes muscle activity and patterns movement (Figure 3-1A). 
Cholinergic motor neurons provide excitatory synaptic drive onto inhibitory GABA 
motor neurons and onto body wall muscles. GABA motor neurons make inhibitory 
synaptic connections onto opposing musculature, reinforcing a sinusoidal locomotory 
pattern.  
To address whether excitatory motor neurons are important for shaping functional 
connectivity in this circuit, we first examined unc-3 mutants, in which cholinergic motor 
neurons fail to terminally differentiate (Kratsios et al., 2012). unc-3 encodes the sole C. 
elegans homolog of the COE family of transcription factors and is essential for the 
terminal differentiation of A and B cholinergic motor neurons (Kratsios et al., 2012).  In 
unc-3 mutants, these neurons are born and express generic neuronal markers, but fail to 
express cholinergic-specific genes. Thus, cholinergic innervation of both body wall 
muscles and GABA motor neurons should be severely disrupted in unc-3 animals. To test 
this idea, we made whole-cell patch electrophysiology recordings of synaptic events from 
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body wall muscles of adult unc-3 mutants and found significant defects in excitatory 
transmission. Specifically, the frequency of endogenous excitatory post-synaptic currents 
(EPSCs) was significantly reduced compared to the wild type (data not shown). 
Nonetheless, a low level of cholinergic transmission remained detectable. This residual 
cholinergic transmission may reflect activity of cholinergic VC motor neurons, which do 
not require unc-3 for expression of cholinergic markers (Kratsios et al., 2012). Similar to 
the A and B classes, VC motor neurons innervate both GABA neurons and muscle, but 
by comparison, account for far fewer synapses. Thus, our results are consistent with the 
idea that mutation of unc-3 reduces cholinergic drive in the motor circuit by decreasing 
the number of cholinergic synaptic contacts onto body wall muscles and GABA motor 
neurons. 
We next sought to determine whether the reduced excitatory drive associated with 
mutation of unc-3 affected inhibitory transmission onto muscles. Using conditions that 
isolated inhibitory transmission, we measured both endogenous and evoked inhibitory 
synaptic currents (IPSCs) from unc-3 mutants. Remarkably, inhibitory events were 
almost completely eliminated under our standard recording conditions (1 mM Ca2+). For 
both wild type and unc-3, the rate of inhibitory events increased with higher levels of 
extracellular Ca2+ (5 mM); nonetheless, the endogenous IPSC rate in unc-3 mutants was 
dramatically reduced compared to the wild type recorded under the same conditions 
(Figure 3-1 B, C).  
The amplitude of spontaneous release events rose from 31.30±0.21 pA in wild 
type animals to 35.74±0.33 pA  in unc-3 mutants reflecting an increase in muscle 
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response to GABA release (Figure 3-1 D).  The frequency of spontaneous GABA release 
is decreased in unc-3 animals (14.78±2.1Hz compared to 38.61±3.9 Hz in wild type), 
presumably due to the lack of direct synaptic input from the cholinergic motor neurons 
(Figure 3-1 E).  The kinetics of evoked response were also altered in these animals, with 
an increase decay time for body wall muscle response to GABA motor neuron activation 
suggesting an expanded postsynaptic receptor field in unc-3 mutant animals.  These data 
show that cholinergic motor neuron activity influences the functional properties of 
GABA synapses.  
Changes in GABA functional properties in unc-3 mutant animals suggest that 
these neurons are able to alter properties of other synapse types within the circuit.  In 
order to determine if GABA motor neurons are able to alter cholinergic functional 
properties, we recorded evoked responses from unc-30 mutant animals.  unc-30 encodes a 
homeodomain transcription factor that is required for the terminal differentiation of 
GABA motor neurons (Jin et al., 1994; Eastman et al., 1999).  We did not observe any 
differences in cholinergic evoked responses in unc-30 mutant animals compared to wild 
type (Figure 3-S1).  These data suggest that GABA motor neuron activity is unable to 
alter cholinergic synapse function leading to a model where cholinergic motor neuron 
activity is the master regulator of circuit activity.  
 
Cholinergic input patterns GABA synaptic outputs 
Our electrophysiological studies suggested that reduced excitatory signaling altered 
inhibitory transmission. In order to address whether these functional changes might 
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reflect alterations in circuit development or assembly, we examined the structure and 
synaptic connectivity of the motor circuit in unc-3 mutants. We first sought to determine 
whether body wall muscles and GABA motor neurons developed normally by examining 
their gross morphology. In wild type animals, body wall muscles project membrane 
extensions, called muscle arms, to the nerve cords where muscle arm termini bifurcate 
and project lengthwise along the nerve cord, forming en passant synaptic connections 
with motor neurons (Dixon and Roy, 2005b). We used muscle-specific expression of 
membrane bound mCD8-GFP (him-4p::mCD8-GFP)(Collins and Koelle, 2013);(Lee and 
Luo, 1999) (Dixon and Roy, 2005b)  to visualize muscle cell bodies and muscle arms 
(Figure 3-S2 A’-C’). Despite a dramatic reduction in synaptic innervation from 
cholinergic motor neurons, neither gross muscle morphology nor the extent of muscle 
membrane contact with the nerve cord were appreciably altered in unc-3 mutants (Figure 
3-S2 D).   
In addition to forming neuromuscular synapses with body wall muscles, cholinergic 
motor neurons also synapse directly onto inhibitory GABA motor neurons. We used cell-
specific expression of mCherry to visualize GABA motor neurons (Punc-47::mCherry) 
in unc-3 mutants. Similar to the case for muscle cells, disruption of cholinergic 
innervation did not produce obvious defects in GABA motor neuron number, positioning 
or morphology (Figure 3-S2 A-C). Thus, our results suggest that both body wall muscles 
and GABA motor neurons develop normally in the absence of cholinergic inputs from A 
and B motor neurons. 
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The above results indicated that the functional changes in inhibitory transmission we 
observed did not arise due to defects in the gross morphological development of either 
muscles or GABA motor neurons. Therefore, we hypothesized that altered inhibitory 
function may have been caused by structural changes at inhibitory synapses. To address 
this possibility, we examined the structure and distribution of GABA synapses in a 
transgenic strain co-expressing the synaptic vesicle marker mCherry-RAB-3 in GABA 
motor neurons together with the GFP-tagged GABAA-like receptor UNC-49 in muscles. 
Interestingly, we found that mutation of unc-3 produced significant changes in the size 
and positioning of GABA synapses. In wild type animals, GABA synapses are evenly 
spaced along the ventral nerve cord, with presynaptic vesicles and post-synaptic GABA 
receptor clusters in close apposition (Figure 3-2 A, D). With disruption of cholinergic 
innervation (unc-3), we observed an altered distribution of GABA synaptic clusters as 
well as a significant increase in their size (Figure 3-2 B, E, F and 3-S3). Specifically, the 
average size of both presynaptic mCherry-RAB-3 puncta and postsynaptic UNC-49-GFP 
puncta increased significantly, while the number of pre- and post-synaptic puncta was 
significantly decreased (Figure 3-2 E, F). Localization of the active zone marker SYD-2-
GFP and UNC-10::GFP as well as the synaptic vesicle marker SNB-1::GFP were 
similarly affected (Figure 3-S4). We did not observe obvious changes in the apposition 
of presynaptic mCherry-RAB-3 and postsynaptic UNC-49-GFP fluorescent signals 
(Figure 3-2 D); however, we noted large regions of the ventral nerve cord lacked 
detectable fluorescence in unc-3 mutants (56 ± 4%, compared to 20 ± 2% in the wild type, 
p<0.01), indicating that the patterning of GABA synaptic outputs onto muscles was 
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disrupted (Figure S3 D-G).  Our analysis of unc-3 mutants suggests that cholinergic 
innervation within the motor circuit may shape inhibitory connectivity at the NMJ. 
To gain further support for the notion that the defects in inhibitory connectivity we 
observed arose due to a disruption in cholinergic innervation, we examined inhibitory 
synapse connectivity following genetic ablation of ACh motor neurons. To ablate ACh 
motor neurons, we expressed a transgene engineered to encode a putative gain-of-
function variant of the acetylcholine receptor subunit ACR-2, ACR-2(L/S) (Barbagallo et 
al., 2010). Expression of ACR-2(L/S) produces cell-autonomous death of cholinergic 
motor neurons during late embryogenesis. We found that genetic ablation of ACh motor 
neurons by ACR-2(L/S) expression caused defects in inhibitory synapses that were 
similar to those observed for unc-3 mutants. Specifically, we observed a significant 
increase in the size of both mCherry-RAB-3 presynaptic structures and postsynaptic 
UNC-49-GFP clusters, as well as a significant decrease in their number (Figure 3-2C-F). 
Further, the proportion of nerve cord lacking pre- or post-synaptic fluorescence was 
significantly increased. As was the case for unc-3, we did not observe gross 
morphological changes in the muscles or GABA neurons of ACR-2(L/S) animals, 
indicating that the altered distribution of RAB-3 and UNC-49 was not caused by defects 
in cell morphology (Figure 3-S2). 
As our findings above indicated that the area of membrane contacts between motor 
neurons and muscles was unaffected by disrupting cholinergic innervation, we next 
sought to determine whether the altered distribution of GABA synaptic clusters reflected 
a failure of synapse assembly associated with specific muscle arm termini or an altered 
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distribution within individual muscle arms. We analyzed the localization of GABA 
receptors in individual muscle arm termini in the wild type, unc-3 mutants and transgenic 
ACR-2(L/S) animals. When examined at the level of individual muscle arms in wild type 
animals, GABA receptors are distributed evenly across the full extent of the muscle arm 
terminus (Figure 3-S5). In contrast, disruption of presynaptic cholinergic innervation 
produced irregularly distributed, larger aggregates of UNC-49-GFP clusters, leading to 
extended regions of muscle membrane that lack GABA receptor clusters (Figure S5). 
Taken together, our analysis of inhibitory synapses in unc-3 mutants and ACR-2(L/S) 
transgenic animals supports the hypothesis that presynaptic innervation from cholinergic 
motor neurons play a central role in shaping GABA synaptic outputs. 
 
GABA synapse patterning is unaffected by global reductions in synaptic activity 
To investigate whether the effects of cholinergic denervation on GABA synapses 
arose due to a reduction in neurotransmission within the circuit, we next examined 
GABA synapse patterning in unc-64 and unc-13 mutants. unc-64 encodes a C. elegans 
ortholog of syntaxin, a SNARE (soluble N-ethylmaleimide-sensitive factor attachment 
protein (SNAP) receptor) family member, while unc-13/Munc13 encodes a conserved 
synapse-associated diacylglycerol binding protein (Saifee et al., 1998), (Maruyama and 
Brenner, 1991), (Brose et al., 1995). Both UNC-64/syntaxin and UNC-13/Munc13 are 
essential components of vesicular release machinery and mutation of either of these genes 
in C. elegans impairs synaptic vesicle fusion at the plasma membrane, resulting in a near-
complete disruption of neurotransmitter release (Richmond et al., 1999; Hammarlund et 
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al., 2007b). Consistent with previous work, we found that mutations in unc-13 and unc-
64 did not alter the size or distribution of GABA synapses (Figure 3-3). Additionally, we 
evaluated GABA synapse localization in animals lacking vesicular release due to 
expression of tetanus toxin in both cholinergic and GABAergic motor neurons (Figure 3-
3D). The size and number of GABA presynaptic release sites and postsynaptic receptor 
clusters were not appreciably altered by the simultaneous loss of synaptic vesicle release 
in GABA and ACh motor neurons (Figure 3-3 E,F). Thus, our analysis indicates that 
global reductions in neurotransmission are insufficient to disrupt GABA synapses, while 
specific disruption of ACh motor neurons alters the size and positioning of GABA 
synapses. 
 
Vesicular release from cholinergic neurons shapes GABA synapses 
We envisioned two alternative models that could account for the above findings. 
One possibility is that there is a requirement for ACh neurons that occurs independently 
of transmission onto GABA neurons, for example through interactions between cell 
surface proteins expressed by ACh and GABA neurons. Alternatively, GABA synapse 
formation may be sensitive to relative levels of excitatory and inhibitory signaling. To 
distinguish between these possibilities, we selectively disrupted vesicular release from 
either excitatory or inhibitory motor neurons using neuron-specific expression of tetanus 
toxin light chain (TeTx). Cell-specific expression of TeTx in cholinergic and GABAergic 
motor neurons led to reduced motor neuron function but was insufficient to alter motor 
neuron morphology or outgrowth (Figure 3-S6).  
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Specific TeTx expression in ACh motor neurons produced severe abnormalities in 
GABA synapses (Figure 3-4A, B), including enlargement of both presynaptic mCherry-
RAB-3 and postsynaptic receptor clusters, as well as gaps in fluorescence that were 
similar to those observed for unc-3 mutants and acr-2(L/S) transgenic animals (Figure 3-
4E, F). In contrast, specific expression of TeTx in GABA motor neurons produced no 
discernible changes in the size or distribution of mCherry-RAB-3 clusters in GABA 
neurons (Figure 3-4C, E, F). We did note diffuse post-synaptic labeling, consistent with 
previous reports that a vesicle associated signal may be important for clustering of 
GABA receptors (Gally and Bessereau, 2003b), complicating analysis of individual 
puncta. However, the percentage of the cord devoid of post-synaptic signal was 
unchanged in GABA specific TeTx strains compared to wild type (Figure 3-S7), 
consistent with the idea that patterning of GABA synapses was unchanged by specific 
disruption of vesicle release from GABA neurons.  
Additionally, we found that the size and distribution of GABA synapses in unc-
25/glutamic acid decarboxylase (GAD) mutants that are defective in GABA biosynthesis 
were indistinguishable from the wild type, consistent with previous reports (Jin et al., 
1999b); (Gally and Bessereau, 2003b) and (Figure 3-4D, E, F). Taken together, our 
results suggest that vesicle release from ACh motor neurons is required for the regulation 
of GABA synapse size and distribution while vesicle release from GABA neurons is not 
essential.  
 
100
Acetylcholine release onto GABA motor neurons instructs inhibitory synaptic 
patterning 
 Cholinergic motor neurons synapse directly onto GABA motor neurons and body 
wall muscles. Thus, our above findings may indicate that cholinergic motor neurons 
regulate GABA synapse patterning through direct synaptic activation of GABA motor 
neurons. unc-17(e245) mutants are defective in a vesicular ACh transporter (vAChT) that 
loads ACh into synaptic vesicles, and have strong locomotory defects as well as 
numerous other phenotypes consistent with decreased cholinergic transmission (Alfonso 
et al., 1993); (Brenner, 1974b); (Rand and Russell, 1984). The e345 allele produces 
strong reduction-of-function effects and we selected it for our studies as an 
experimentally tractable alternative to unc-17 null alleles, which are lethal (Alfonso et al., 
1993). Mutation of unc-17 produced significant defects in GABA synapse patterning, 
including enlarged presynaptic release sites and postsynaptic receptor clusters, as well as 
gaps in the distribution of synapses (Figure 3-5A, B). These effects were less 
pronounced compared to those observed for specific expression of TeTx in cholinergic 
motor neurons, suggesting ACh release is less strongly impaired by the hypomorphic 
unc-17 mutation or involvement of additional ACh-independent signals important for 
synapse patterning.  
To address whether the effects of decreased ACh release reflected a requirement for 
ACh signaling onto GABA motor neurons or onto muscles, we examined GABA 
synapses in animals lacking functional iAChRs at the NMJ (unc-29;acr-16 double 
mutants). unc-29 and acr-16 encode essential subunits of the two AChR classes that 
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mediate cholinergic neurotransmission onto muscles. Combined mutation of these genes 
produces a complete loss of muscle responses to ACh application (Francis et al., 2005b). 
Eliminating synaptic activation of muscles did not alter the density or positioning of 
GABA release sites, suggesting that GABA synapse patterning was unaffected (Figure 3-
5C-E). We did note a slight reduction in the number of postsynaptic receptor clusters in 
unc-29;acr-16 double mutants compared to wild type. These specific effects on the post-
synapse are most consistent with homeostatic changes in muscles in the absence of 
cholinergic innervation.  Our findings support a model where direct activation of GABA 
motor neurons by acetylcholine release instructs GABA synapse patterning.  
 
Acetylcholine release is required during a developmental critical period to instruct 
GABA synapse localization 
Our previous genetic analysis showed that cholinergic release onto GABA motor 
neurons is required for GABA synapse patterning, but did not indicate whether these 
effects are due to deficits in synaptic development or maintenance. To investigate 
whether the alterations in GABA synapse size and patterning we observed reflected a 
requirement for ACh signaling during specific developmental periods, we reversibly 
disrupted acetylcholine signaling using a temperature sensitive allele (y226) of the C. 
elegans choline acetyltransferase gene (ChAT), cha-1, leading to decreased ACh 
biosynthesis (Rand and Russell, 1984);(Zhang et al., 2008). At the permissive 
temperature (15°C), temperature-sensitive cha-1/ChAT mutants proceed normally 
through development, with the full complement of motor neurons developing similarly to 
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wild type (Figure 3-6A, B).  Inhibitory synapse development also proceeds normally at 
15°C in both wild type and cha-1/ChAT mutants, forming a uniform punctate pattern 
along the ventral nerve cord with proper alignment of pre- and postsynapse (Figure 3-6C, 
D). cha-1(y226) mutants become uncoordinated within minutes (<10) when switched to a 
non-permissive temperature (25°C), consistent with rapid impairment of cholinergic 
transmission, and these effects are completely reversible upon shifting back to the 
permissive temperature (data not shown).  
We first assessed the requirement for ACh signaling during development by 
blocking ACh release for a 24-hour period of time spanning the highly synaptogenic 
window between hatch and the second larval stage. We then allowed animals to grow to 
adulthood at a permissive temperature and assessed GABA synapse morphology in 
young adult animals (24 hours post-L4). This manipulation resulted in a disruption in 
GABA synapse patterning, including gaps in the distribution of both pre- and 
postsynaptic puncta and a mild increase in puncta size.  
To precisely define a developmental time window in which ACh signaling was 
required, we examined the effects of removing acetylcholine release for 8hr and 4hr 
windows beginning during the first larval stage. We identified a four-hour time window 
beginning 12 hours after hatch at 150C (late L1) during which a shift to the restrictive 
temperature was sufficient to produce significant defects in GABA synapse patterning 
(Figure 3-6 F-J).  In particular, we found that a 4-hour shift to the restrictive temperature 
produced a significant increase in areas devoid of pre- or post-synaptic signal though 
puncta size only increased marginally compared to wild type (Figure 3-6G-J). 
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Importantly, we did not observe these effects in cha-1 mutants grown at 150C or in wild 
type animals that experienced the same shift in temperature (Figure 3-6D, E). Our 
findings indicate that ACh release is critical during the end of the first larval stage to 
instruct GABA synaptic patterning, defining a critical developmental period during 
which cholinergic synaptic activity regulates the development of inhibitory synapses. 
 
Acute loss of acetylcholine release in the adult nervous system leads to a decrease in 
GABA synapse size.  
Our analysis of GABA synapses in the adult nervous system suggested that while 
the patterning of established synaptic fields was unaffected by changes in ACh 
transmission the area of both presynaptic release sites and postsynaptic receptor clusters 
are significantly reduced upon removing ACh release in adult animals. To explore 
whether this represented a form of plasticity at adult GABA synapses, we reduced 
acetylcholine release by shifting animals to the restrictive temperature for a four-hour 
period in early adulthood, after the nervous system has been fully established (Figure 3-
7). These animals were grown at the permissive temperature and staged as young adults, 
24 hours after the fourth larval stage. These young adult animals were then shifted to the 
non-permissive temperature for four hours and inhibitory synapses were immediately 
images. Restricting cholinergic transmission produced a significant decrease in the size of 
presynaptic mCherry-RAB-3 clusters and post-synaptic UNC-49-GFP puncta without 
significant effects on the distribution of synaptic clusters (Figure 3-7A-D, I-L). The 
same temperature shift did not produce significant changes at GABA synapses of wild 
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type animals, consistent with this being a specific result of acute reductions in ACh 
release in cha-1/ChAT mutants. Interestingly, increasing the time that cha-1/ChAT 
mutants were exposed to the restrictive temperature produced further decreases in the size 
of GABA pre- and postsynaptic clusters, suggesting that inhibitory synapse size 
decreases proportionally with the length of time that excitatory ACh transmission is 
impaired (Figure 3-7 E, F, I-L). We were unable to test more prolonged temperature 
shifts because adult animals left at 25 C longer than eight hours became unhealthy 
leading to nonspecific effects on nervous system structure.  These results suggest that 
inhibitory synapse size is scaled proportionately to the amount of excitatory release 
within the circuit hinting at the presence of a compensatory mechanism for balancing 
excitation and inhibition within the circuit.  
In order to further characterize the relationship between the levels of excitatory 
release and inhibitory synapse size, we reintroduced ACh to the circuit after depravation 
and assessed GABA synapse size for recovery. A four-hour recovery period was 
sufficient to restore wild type body posture and locomotion in cha-1 mutant animals (data 
not shown). Based on this behavioral observation, adult animals were shifted to the non-
permissive temperature as above then immediately placed back at the permissive 
temperature and allowed to recover for four hours (Figure 3-7 G, H). Decreases in the 
size of inhibitory synaptic clusters were completely reversed following a four hour 
recovery period at 15°C, indicating that these changes in GABA synapses were reversible 
(Figure 3-7 I, J) and could be normalized by restoring wild type levels of excitatory ACh 
transmission. Our findings indicate that a temporally restricted period of reduced ACh 
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release at adult synapses leads to reductions in the size of GABA synapses without 
obvious effects on synapse distribution. The reversible effects of decreased ACh 
transmission on GABA synapses suggest that compensatory mechanisms are present in 
the adult nervous system, and act by scaling inhibitory synapse size in response to 
decreases in excitatory transmission, providing a mechanism balancing levels of 
excitatory and inhibitory neuromuscular signaling in adults. 
 
Discussion 
The activity of the GABAergic nervous system plays an essential role in the 
establishment and refinement of neuronal networks within the mammalian brain (Hensch 
and Fagiolini, 2005b); (Ben-Ari, 2002b). Though the importance of inhibitory activity 
during development is well understood, little is known about how the synaptic patterning 
and the functional range of activity in the inhibitory nervous system are established 
during network development in vivo.  In this study, we use C. elegans as a model system 
to show that excitatory drive onto GABAergic neurons during early development is an 
essential driving force behind inhibitory synapse function and patterning.  
In the C. elegans motor circuit, cholinergic motor neurons provide the primary 
excitatory input onto both body wall muscles and GABAergic motor neurons. We found 
that in the absence of functional cholinergic neurons, both the body wall muscle and the 
GABA motor neurons were able to establish normal morphology and outgrowth.  This 
result suggests that cell intrinsic mechanisms are in place to facilitate the gross 
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morphology of the motor circuit while activity-dependent mechanisms dictate synaptic 
connectivity.    
Electrophysiological analysis of inhibitory signaling showed that GABA motor 
neurons remain functional in the absence of excitatory input.  This data implies that 
presynaptic activation of GABA motor neurons is not essential for neuronal function, 
providing evidence for the existence of intrinsic activity within the GABA motor neurons.  
Functional analysis of inhibitory activity in unc-3(e151) mutant animals show an increase 
in the amplitude of spontaneous release in animals chronically lacking excitatory drive. 
This data suggests that excitatory drive onto the GABA motor neurons is required for the 
refinement of inhibitory synapses.  Interestingly, we found that changes in inhibitory 
neuron function (unc-30 mutants) were unable to alter excitatory synapse function 
leading us to hypothesize that excitatory neurons act as master regulators of activity 
during development to control synapse patterning and functional properties.   
In addition to functional changes, we also observed an increase in GABA synapse 
size and patterning in the absence of functional cholinergic motor neurons. Studies in the 
mammalian cortex have reported a correlation between excitatory synapse size and 
synaptic efficacy. For example, at glutamatergic synapses, stronger synapses have larger 
dendritic spines and an increased number of glutamate receptors at the postsynaptic 
density (Matsuzaki et al., 2004b).  When combined with functional analysis, our results 
suggest that synapse size is also an indicator of synapse strength for inhibitory synapses.  
 We found that global reductions in neurotransmission were insufficient to alter 
inhibitory synapse patterning, leading us to hypothesize that the balance of excitation and 
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inhibition acted as the driving force behind synapse pattering.  Our finding that selective 
disruption of cholinergic release phenocopied animals chronically lacking functional 
cholinergic neurons, while disruption of inhibitory neurons had no effect on presynaptic 
patterning, further supported this hypothesis.  Additionally, we show that loss of ACh 
release, but not loss of cholinergic neurotransmission directly onto body wall muscle, led 
to altered GABA receptors.  These results support our model that cholinergic 
neurotransmission triggers activity-dependent mechanisms, perhaps transcriptional or 
translational programs, within the GABA motor neurons to instruct GABA synapse 
patterning during development.  
In the mammalian brain, the inhibitory nervous system has been implicated as a 
key player in determining the timing of critical period plasticity (Fagiolini and Hensch, 
2000b); (Huang et al., 2007).  Multiple studies have shown the ability of GABA 
interneurons to control key aspects of cortical circuits including neuronal excitability, 
integration and the temporal oscillations of excitatory networks (Swadlow, 2003b); 
(Pouille and Scanziani, 2001b); (Somogyi and Klausberger, 2005).  Though many studies 
have focused on roles for inhibitory signaling in critical period plasticity, little is known 
about factors that define critical periods in inhibitory synapse development.  In this study 
we identified a critical period during which excitatory drive onto GABA motor neurons 
set inhibitory activity levels and instruct inhibitory patterning. The circuit is unable to 
recover if activity is disrupted during this critical period suggesting that specific activity-
dependent programs must occur in the immature circuit in order to produce a functional 
circuit.  
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In contrast, decreased excitatory drive onto the established circuit leads to 
compensatory scaling of inhibitory synapses hinting at the presence of homeostatic 
mechanisms that work to maintain circuit activity within a functional range. The synaptic 
scaling we observe in the established nervous system correlates to what is observed in 
circuits where homeostatic plasticity is functioning appropriately to maintain circuit 
function.  This data implies that distinct activity-dependent mechanisms function in 
GABA motor neurons during development and in the adult nervous system to regulate 
inhibitory signaling.  
In this study we provide evidence that the C. elegans motor circuit is a viable genetic 
system for studying activity-dependent regulation of circuit development in vivo. Our 
model provides an ideal platform to carry out further genetic studies to identify the 
molecular mechanisms underlying the opening and closing of critical period windows. 
Understanding the differences between highly plastic brain during early developmental 
critical periods and less plastic adult brains may lead to the ability to aid circuit rewiring 
alter brain trauma such as stroke or for pharmacological ways to correct 
neurodevelopmental disorders such as autism spectrum disorders and epilepsy.  
 
Methods 
C. elegans Strains 
 C. elegans strains were grown at room temperature (22-240C) on nematode 
growth media (NGM) plates seeded with the Escherichia Coli strain OP50.  Wild type 
represents the N2 Bristol strain.  Mutant lines were obtained from the Caenorhabditis 
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Genetics Center (GCG), funded by the NIH Office of Research Infrastructure Programs 
(P40 OD010440). All transgenic strains presented were made by injecting plasmid DNA 
(30-50ng/ul) into the germ line using standard methods (Mello et al., 1991b). Data 
presented represents a single transgenic line unless otherwise indicated.  Strains were 
made using either a lin-15 co-injection marker for rescue (lin-15(n765ts) or using a 
fluorescent co-injection marker located in the pharynx of the animal (lgc-11::GFP, lgc-
11::mCherry), details for each strain can be found in the strain list.   All co-injection 
markers were injected at 30ng/ul and multiple transgenic lines were obtained for each 
transgene.  Selected transgenes were integrated using x-ray bombardment and outcrossed 
to wild type animals.  
 
Molecular Biology 
 Him-4p::mCD8::GFP.  Plasmid was constructed using the two-slot Gateway 
Cloning system.   Entry Vector: the him-4p promoter fragment (2164bp) was amplified 
from pPRZ138.2 (a gift from Peter Roy) and cloned into the d-TOPO Vector (Invitrogen). 
Destination Vector: mCD8-GFP (1586bp) was amplified from plasmid PKMC72 by PCR 
using a  
forward primer ATTAGGTACCATGGCCTCACCGTTGACCCG (OMF735) and a  
reverse primer GCTAGCCGGCTTATTTGTATAGTTCATCCATG (OMF736).   
Respectively, each primer contained a restriction site KpnI and NgoMIV. The mCD8-
GFP PCR product and a destination vector (pDest-16) were digested with NgoMIV and 
110
KpnI for 2 hours at 37oC.  All digested products were size separated using agarose gel 
electrophoresis, purified, and ligated overnight at 4oC with T4 DNA ligase.   
 Tetanus toxin constructs: All tetanus toxin plasmids were constructed using the 
two-slot gateway system. Entry Vectors: Cholinergic-specific tetanus toxin: A 3394bp 
fragment of Pacr-2 was amplified from pBB67 and subcloned into the d-TOPO vector 
(Invitrogen).  GABAergic-specific tetanus toxin: A 1166bp fragment of Punc-47 was 
amplified from pPRB65 and subcloned into the d-TOPO vector (Invitrogen).   
Destination Vector: Tetanus Toxin Light Chain (1394bp) was amplified from plasmid 
TetX-pWD157 (Alkema Lab) by PCR using a  
forward primer ATTAACCGGTATGCCGATCACCATCAACAAC (OMF883) and a  
reverse primer GCTAGCCGGCTTAAGCGGTACGGTTGTACA(OMF884).   
Respectively, each primer contained a restriction site AgeI and NgoMIV. 
The final expression clones were generated by recombining the respective entry vectors 
with the tetanus toxin destination vector using an LR clonase reaction (Invitrogen). The 
Tetanus Toxin PCR product and a destination vector (pDest-8) were digested with AgeI 
and NgoMIV for 2 hours at 37oC. All digested products were size separated using 
agarose gel electrophoresis, purified, and ligated overnight at 4oC with T4 DNA ligase.   
 
Electrophysiology 
Endogenous postsynaptic currents (PSCs) were recorded from body wall muscles as 
described previously (Francis et al., 2005b). The extracellular solution consisted of the 
following (in mm):150 NaCl, 5 KCl, 4 MgCl2, 1 CaCl2, 15 HEPES, and 10 glucose, pH 
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7.4, osmolarity adjusted with 20 sucrose. The intracellular fluid consisted of the 
following (in mm):115 K-gluconate, 25 KCl, 0.1 CaCl2, 50 HEPES, 5 Mg-ATP, 0.5 Na-
GTP, 0.5 cGMP, 0.5 cAMP, and 1 BAPTA, pH 7.4, osmolarity adjusted with 10 sucrose. 
For some experiments measuring GABA-mediated currents, the intracellular solution 
contained 115 mm KCl and 25 mm K-gluconate, enabling measurement of inward 
inhibitory current responses (chloride efflux). At least 60–90 s of continuous data were 
used in the analysis. Data analysis was performed using Igor Pro (Wavemetrics) and Mini 
Analysis (Synaptosoft) software. Statistical comparisons were made by Student's t test 
using GraphPad Prism. 
Aldicarb Assay 
Aldicarb assays were performed on adult animals (24 hours post L4) at room 
temperature (220C -240C ) with the researcher blind to the genotypes of the plates.  
Staged animals (10/plate) were transferred to NGM plates containing 1mM Aldicarb 
(ChemService) and accessed for movement every 15 minutes for two hours.  Data 
represents the mean ±SEM for a minimum of ten assays for each genotype.  
 
Microscopy and Image analysis 
 Confocal microscopy was performed using a Zeiss LSM510 microscope with 
LSM Pascal 5 imaging software (Zeiss).  Images were analyzed using ImageJ software 
(open source).   Full worm images were obtained using a 63x oil lens and piecing 
together the resulting images using Photoshop software (Adobe).  
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Synapse density was calculated from a line-scan analysis of a 50uM section of the 
ventral nerve cord directly posterior to the vulva of the animal.  A minimum fluorescence 
threshold was set to identify synaptic peaks (1500a.u. for cholinergic synapses and 
500a.u. for GABAergic synapses).  Peaks were identified as two or more consecutive 
data points above the predetermined threshold and spaces were defined as two ore more 
data points below threshold.  Synapse area was calculated by thresholding a 50uM span 
of the ventral nerve cord using standardized parameters, separating particles using the 
ImageJ watershed algorithm and performing the ImageJ analyze particles function.   
Particles below a defined threshold (≤0.2uM2) were excluded as background. 
Muscle arm number was counted manually.  Muscle arms from ventral muscle cells 
17 and 19 were included in the analysis.  Percent of nerve cord covered was measured 
using ImageJ software (open source) to measure the length of the ventral midline of the 
posterior body wall muscles.  The total length of muscle arm termini were then measured 
and used to calculate the percent of the midline covered.  
 
cha-1 time course 
Developmental Shift: Embryos were staged at the 21+ cell stage and grown at 150C for 12 
hours when they were shifted to 250C for four hours and then returned to 150C until 
adulthood.  Animals were imaged at young adulthood, staged at L4 and allowed to grow 
up at 150C for 12 hours.  
Adult Shifts and Recovery: Wild type and cha-1 animals were cultured at 150C using 
standard methods.  Animals were staged at L4 and allowed to develop to adulthood (12 
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additional hours at 150).  Young adult animals were then shifted to 250C for either four or 
eight hours and imaged immediately.  Young adult recovery animals were shifted to 250C 
for four hours, then placed back at 150C for four hours before imaging.  
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Figure 3-1:  GABA activity increases in the absence of functional cholinergic 
neurons 
A. Diagram of the C. elegans motor circuit with excitatory cholinergic motor neurons 
(Gray) synapsing onto inhibitory GABAergic motor neurons (purple) and onto body wall 
muscles (brown).  B, C: Examples of GABA spontaneous release events in wild type (B) 
and unc-3(e151) mutant animals (C). D. Quantification of the frequency of spontaneous 
GABA events. Student t-test, ***p,0.0001. E. Cumulative distribution of amplitude of 
spontaneous IPSCs in wild type and unc-3 mutant animals.  Kolmogorov-Smirnov test. 
***p=0.0007.  
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Figure 3-2: GABA synapse patterning requires functional cholinergic motor 
neurons. 
A-C. Confocal images of the ventral nerve cord in adult animals co-expressing a GABA 
presynaptic marker (Punc-47::mCherry::RAB-3) and a GABA postsynaptic marker 
(UNC-49::GFP) in wild type (A), unc-3(e151) (B) and ACR-2(L/S) (C) animals.  
Alterations in synapse localization are characterized as gaps in synapse distribution 
(bracket) and enlarged puncta (^).  Asterisks indicate GABA motor neuron cell bodies. 
Scale bar: 20um.   D. Quantification of the ratio of the number of presynaptic puncta to 
postsynaptic puncta. No statistical significance is observed. E. Quantification of synapse 
cluster number per 50um area of the ventral nerve cord.  All data has been normalized to 
wild type. F. Quantification of synaptic cluster area for GABAergic synapses. Each graph 
represents the mean ± SEM of at least ten animals/genotype. Student T-test *p<0.05, 
**p<0.01, ***p<0.0001 
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Figure 3-3: Global reductions in neurotransmission are insufficient to alter GABA 
synapse localization.  
A-D. Confocal images of the ventral nerve cord adult animals co-expressing a GABA 
presynaptic marker (Punc-47::mCherry::RAB-3) with a GABA postsynaptic marker 
(UNC-49::GFP) in genotypes indicated. Carrots mark enlarged puncta and brackets 
indicate gaps in synapse distribution. Scale bar: 20um.  E. Quantification of presynaptic 
(black bars) and postsynaptic (gray bars) cluster density for all genotypes, normalized to 
wild type. F. Quantification of presynaptic (black bars) and postsynaptic (gray bars) area 
for genotypes indicated. Each graph represents the mean ± SEM of at least ten 
animals/genotype. Student t-test *p<0.05, **p<0.01, ***p<0.0001. 
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Figure 3-4: Cell specific silencing of cholinergic motor neurons leads to abnormal 
GABA synapse localization.  
A-C. Confocal images of adult animals expressing GABA synapse markers in wild type 
animals (A) and transgenic animals cell-specifically expressing tetanus toxin light chain 
in cholinergic (B) or GABAergic (C) motor neurons.  Large accumulations of receptor 
(^) and gaps in synapse coverage (bracket) are observed in cholinergic-specific tetanus 
toxin strains. Scale bar: 20uM.  D. Quantification of number of presynaptic (black bars) 
and postsynaptic clusters (gray bars) in 50uM spans of the ventral nerve cord for all 
genotypes, normalized to wild type. E. Quantification of presynaptic area (black bars) 
and postsynaptic area (gray bars) for genotypes indicated.  For all quantification, graphs 
represent the mean ± SEM of at least ten animals/genotype. Student t-test *p<0.05, 
**p<0.01, ***p<0.0001 
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Figure 3-5: Cholinergic neurotransmission onto body wall muscle is dispensable for 
GABA synapse patterning 
A-D. Confocal images of the ventral nerve cord in adult animals co-expressing a GABA 
synaptic markers (Punc-47::mCherry::RAB-3,UNC-49::GFP) in wild type (A), animals 
with reduced GABA release (unc-25(e156)) (B), animals with reductions in acetylcholine 
release (unc-17(e245)) (C) and animals lacking cholinergic receptors at the 
neuromuscular junction (acr-16(ok789);unc-29(x29)) (D). Large accumulations of 
receptor (^) are seen in unc-17(e245) mutant animals. GABA motor neuron cell bodies 
are marked with asterisks. Scale bar: 20um.  E. Quantification of presynaptic (black bars) 
and postsynaptic cluster density (gray bars) for all genotypes, normalized to wild type. F. 
Quantification of presynaptic area (black bars) and postsynaptic area (gray bars) for 
genotypes indicated. Graphs represent the mean ± SEM of at least ten animals/genotype. 
Student t-test *p<0.05, **p<0.01, ***p<0.0001. 
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Figure 3-6: Excitatory input is required during synaptogenesis to instruct GABA 
synapse localization.  
A-D: Confocal images of the ventral nerve cord in adult wild type and cha-1(y226) 
mutant animals co-expressing GABA pre- and postsynaptic markers (Punc-
47::mCherry::RAB-3 and UNC-49::GFP) grown at the permissive temperature (A,B) and 
after a four hour shift to the non-permissive temperature(C,D) during the first larval stage. 
Carrots indicate accumulations of synaptic markers and brackets indicate gap in synapse 
distribution. Asterisks mark GABA motor neuron cell bodies. Scale bar: 20uM.  E-F: 
Quantification of the presynaptic (E) and postsynaptic (F) cluster density for wild type 
(black bars) and cha-1(y226) mutant animals (gray bar).  G-H: Quantification of 
presynaptic (G) and postsynaptic (H) cluster area for wild type (black bars) and cha-
1(y226) mutant animals (gray bar).  Graphs represent the mean ± SEM of at least ten 
animals/genotype. Student t-test *p<0.05, **p<0.01, ***p<0.0001. 
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Figure 3-7: Acute reductions in acetylcholine release in the mature nervous system 
leads to scaling of GABA synapse size.  
A-H: Confocal images of the ventral nerve cord in adult wild type and cha-1(y226) 
mutant animals co-expressing a GABA pre- and postsynaptic markers (Punc-
47::mCherry::RAB-3 and UNC-49::GFP) grown to young adulthood at the permissive 
temperature(A,B), following a four hour shift to the non-permissive temperature during 
adulthood (C,D), an eight hour shift (E,F) to the non-permissive temperature and after a 
four hour shift and a four hour recovery period (G,H). Asterisks mark GABA motor 
neuron cell bodies. Scale bar: 20uM.  I-J: Quantification of the presynaptic (I) and 
postsynaptic (J) cluster density for wild type (black bars) and cha-1(y226) mutant animals 
(gray bar).  K-L: Quantification of presynaptic (K) and postsynaptic (L) cluster area for 
wild type (black bars) and cha-1(y226) mutant animals (gray bar).  Graphs represent the 
mean ± SEM of at least ten animals/genotype. Student t-test *p<0.05, **p<0.01, 
***p<0.0001. 
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Figure 3-S1: Excitatory motor neuron function does not require GABA motor 
neuron function.  
A,B. Example cholinergic evoked responses from wild type (A) and unc-30(e191) mutant 
animals.  C. Quantification of amplitude of cholinergic evoked response in wild type and 
unc-30 mutant animals.  Quantification shows no significant difference between 
genotypes.  
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Figure 3-S2: Gross motor circuit development occurs independently of excitatory 
inputs.  
A-C. Confocal image of the ventral nerve cord and body wall muscles posterior to the 
vulva of an adult wild type (A), unc-3(e151) mutant (B) and ACR-2(L/S) (C) animals 
expressing mCherry in the GABA nervous system (punc-47::mCherry) (A-C) or a 
membrane bound GFP in the distal row of body wall muscles (him4p::mCD8::GFP) (A’-
C’).  GABA motor neuron cell bodies were identified by cell body position and asterisks 
indicate GABA commissural extensions. Arrows indicate muscle arm extensions and 
arrowheads indicate muscle arm termini. D. Quantification of the percentage of the 
ventral nerve cord covered by muscle membrane.  Graphs show the mean ±SEM for at 
least ten animals/genotype. ns: not significant,  Student t-test.   
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Figure 3-S3: Gaps in inhibitory synapse distribution occur in the absence of 
cholinergic input. 
 A-C. Confocal images of the ventral nerve cord of adult wild type (A), unc-3 (B) and 
ACR-2(L/S) (C) animals expressing GABA pre- and postsynaptic markers (Punc-
47::mCherry::RAB-3, UNC-49::GFP).  Large gaps in synapse distribution are indicated 
with brackets in unc-3 and ACR-2(L/S) animals.  D-F. Confocal images of the ventral 
nerve cord of adult animals expressing GFP tagged GABA receptors at the NMJ (UNC-
49::GFP).  Brackets indicate gaps in receptor cluster distribution. G. Quantification of the 
percent of the ventral nerve cord devoid of GABA receptor clusters. Each graph 
represents the mean ± SEM of at least ten animals/genotype. Student T-test ***p<0.0001 
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Figure 3-S4: Presynaptic density localization is altered in the absence of cholinergic 
input.  
A-F. Confocal images of the ventral nerve cord of adult wild type and unc-3(e151) 
mutant animals expressing a GFP tagged SNB-1 (A-B), SYD-2 (C-D) and UNC-10 (E-F) 
in GABAergic motor neurons. Carrot indicates enlarged presynaptic puncta and asterisk 
indicates GABA motor neuron cell body.  Scale bar: 20um.  G. Quantification of synapse 
cluster number per 50um area of the ventral nerve cord.  All data has been normalized to 
wild type. H. Quantification of synaptic cluster area for GABAergic synapses. Each 
graph represents the mean ± SEM of at least ten animals/genotype. Student T-test 
**p<0.01, ***p<0.0001 
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Figure 3-S5:  Cholinergic and GABAergic receptors are mislocalized within the 
muscle membrane.  
A-C. Confocal images of individual muscle arms in animals expressing GFP tagged 
GABAergic receptors (UNC-49::GFP) in wild type (A), unc-3(e151) (B) or ACR-2(L/S) 
(C).  Muscle membrane boundaries are outlined with white dotted line.  Carrots indicate 
accumulations of postsynaptic receptor.  
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Figure 3-S6: Cell specific expression of tetanus toxin alters neuronal activity without 
altering cell outgrowth or morphology.  
A. Schematic representation of the motor circuit of C. elegans showing the wiring of 
cholinergic neurons (green) and GABAergic neurons (red).  Sites of action for tetanus 
toxin is denoted by black Xs. B. Time course of paralysis of adult animals on 1mM 
Aldicarb, an inhibitor of cholinesterase.  The percentage of animals paralyzed was 
calculated every 15 minutes for two hours.  Each data point represents the average  
±SEM of at least ten drug assays, ten animals/assay. C-E. Confocal images of the 
posterior ventral nerve cord in adult animals co-expressing a transcriptional markers 
labeling cholinergic neurons (Punc-17::GFP) and GABA neurons (Punc-47::GFP) in 
indicated tetanus toxin backgrounds. Cell body identities are labeled in red (GABAergic 
neurons) and green (cholinergic neurons).  
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Figure 3-S7:  The balance of excitatory and inhibitory signaling instructs GABA 
synapse patterning.  
A-D. Confocal images of the ventral nerve cord in adult animals expressing a GFP tagged 
GABA receptor at the neuromuscular junction (UNC-49::GFP).  Cell-specific expression 
of tetanus toxin light chain in cholinergic motor neurons leads to large accumulations of 
receptor (^) and gaps in synapse coverage (bracket).  Cell-specific expression of tetanus 
toxin light chain in GABA motor neurons results in diffusion of postsynaptic receptor 
clusters (dotted line). E. Quantification of the percentage of the ventral nerve cord 
lacking GABA receptor clusters.  Each graphs represents the mean ± SEM of at least ten 
animals/genotype. Student t-test *p<0.05, **p<0.01 
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CHAPTER IV 
 
General Discussion 
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In this thesis I have explored the consequences of modulating activity levels 
within a simple neural circuit.   Through this work, I have made several discoveries about 
the impact of activity on neural circuits; I showed that expression of a gain-of-function 
nicotinic acetylcholine receptor leads to the hyperactivation of cholinergic motor neurons.  
Hyperactivation of these neurons triggered calcium-induced calcium release from the ER 
activating a necrotic-like cell death program.  Interestingly, I observed that in cases 
where cell body death is suppressed, axons continue to deteriorate leading to paralysis.  
This work supports a model where degeneration of the cell body and the axon are 
genetically separable and provides a genetic model for the study of motor axon 
degeneration. 
In later work I focused on the consequences of decreased excitation on neural 
circuit development.  I identified excitatory presynaptic input onto GABAergic motor 
neurons as a driving force behind inhibitory synapse development.  While cellular 
morphology and outgrowth are normal in the absence of excitatory drive, synaptic 
connectivity is highly sensitive to changes in circuit activity. I was able to elucidate 
differential roles for activity in regulating inhibitory synapse morphology during different 
developmental periods.  I identified a critical period window in early development during 
which excitatory drive is required for the establishment of inhibitory synapses.  After this 
critical period, I observed synaptic alterations consistent with scaling of inhibitory 
synapses in responses to changes in excitation. These observations suggest the  
Taken together, my work has provided new insights into the cellular biology of 
activity-dependent circuit changes in an in vivo system.  Additionally, this work has 
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established a genetic model for further study of critical neurological functions such as 
mechanisms of axonal death and critical period plasticity. Disruption of these processes 
in mammalian systems has devastating effects on brain function leading to 
neurodevelopmental and neurodegenerative diseases.  
 
Part 1: Excess activation of cholinergic neurons results in necrotic-like cell death 
Excess ion channel activation plays a role in a variety of human neurological 
diseases from ischemic stroke to ALS.    In Chapter II of this thesis, I carried out a study 
to understand mechanisms underlying cell death in cases of excess ion channel function. 
Through this work I was able to characterize an extrasynaptic ionotropic acetylcholine 
receptor (ACR-2R) expressed in cholinergic neurons.  Introduction of a gain-of-function 
point mutation to the TM2 domain of ACR-2 led to cell-autonomous death of the 
cholinergic motor neurons through a necrotic-like pathway (Figure 4-1). Mutations in 
genes essential for calcium-induced calcium release from the ER blocked cell body death 
but were insufficient to protect against axon destabilization that resulted in paralysis, 
suggesting that cell body death and axon degeneration are genetically separable.  
 
ACR-2R as a model for extrasynaptic modulatory receptors  
The mammalian genome contains 17 nicotinic acetylcholine receptor subunits 
(Graham et al., 2002). These subunits are arranged into pentamers, and the differential 
amino acid sequence of each subunit dictates the function and localization of the receptor 
(Jensen et al., 2005).  A detailed understanding of how individual subunits influence 
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receptor function and localization is required to better understand the roles of AChRs in 
the central nervous system.  C. elegans provides an ideal model to explore ACh receptor 
composition with the genome expressing 29 putative acetylcholine receptor subunits by 
sequence homology.  The receptor composition of nAChRs at the neuromuscular junction 
has been well characterized but little is known about the composition or function of 
neuronal nAChRs. (Francis et al., 2005a);(Fleming et al., 1997);(Richmond and 
Jorgensen, 1999);(Culetto et al., 2004).   
In my work, I have characterized the first neuronal AChR identified in C. elegans, 
which contains the non-alpha acetylcholine receptor subunit: ACR-2.  ACR-2R shows 
restricted expression within cholinergic motor neurons where it is diffusely localized in 
the dendritic compartment.  Behavioral analysis revealed a slight yet significant decrease 
in the number of body bends per minute made by acr-2 mutant animals, while 
pharmacological analysis showed a decrease in cholinergic motor neuron activity in acr-2 
mutants. These results suggest that ACR-2 is participating in an extrasynaptic modulatory 
receptor within cholinergic motor neurons, where it provides small changes in excitability.  
Similarly, a majority of acetylcholine receptors in the mammalian CNS function as 
extrasynaptic modulators of neural circuit excitability, highlighting the conserved nature 
of cholinergic signaling in governing nervous system function.  
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Figure 4-1: Excitotoxic cell death in cholinergic motor neurons summary model 
ACR-2 forms a functional heteromeric receptor with four additional subunits: 
ACR-3, ACR-12, UNC-38 and UNC-63.  Introduction of a putative gain-of-function 
point mutation into the second transmembrane domain of the ACR-2 subunit leads to an 
increased influx of calcium into the cytoplasm. Calcium-induced calcium release from 
the ER is mediated by calnexin and calreticulin and triggers downstream events resulting 
in necrotic-like cell death.  
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Using gain-of-function receptors as a tool to identify receptor composition 
 Due to their modulatory role, the specific function of ACR-2 containing receptors 
in controlling motor neuron excitability was unclear.  To further elucidate its role in 
controlling cholinergic motor neuron excitability, I introduced a gain-of-function 
mutation into the TM2 pore-spanning region of ACR-2.  A wide array of point mutations 
within the TM2 domain were originally characterized using mammalian α7 subunits, and 
these mutants were shown to increase the open time and sensitivity of the receptor (Orr-
Urtreger et al., 2000); (Labarca et al., 1995); (Orb et al., 2004).  We introduced the 
strongest mutation characterized in this study, a leucine to serine substitution at the 9th 
position of the TM2 domain. Expression of this subunit, called ACR-2(L/S), resulted in 
paralysis, suggesting that hyperactivation of cholinergic neurons results in loss of 
cholinergic motor neuron function.   
 ACR-2R is the first neuronal nAChR that has been characterized in C. elegans, 
providing evidence that this gain-of-function strain provided an ideal genetic background 
to identify AChR subunit composition.  Using a combination of forward genetic screens 
and candidate mutant screens for suppressors of ACR-2(L/S)-induced paralysis, we 
identified the subunit composition of the ACR-2 receptor, as well as accessory subunits 
required for the assembly and trafficking of the receptor. The success of this gain-of-
function receptor method validates our technique as a viable way to characterize receptor 
subunit composition.   This allows us to pursue studies of the functional roles of the wide 
array of nAChR subunits encoded by the mammalian and C. elegans genomes, advancing 
our understanding of how specific receptor populations may regulate neuronal classes 
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that are more prone to dysfunction in neurological disease.  
Despite sharing three subunits with the synaptically localized levamisole receptor, 
ACR-2-GFP has a diffuse localization.  This suggests that specific features of the ACR-2 
and/or ACR-3 subunits are key to understanding mechanisms of extrasynaptic receptor 
localization. In the mammalian nervous system, nAChRs can be located synaptically or 
extrasynaptically resulting in differential effects on neuronal function. Closer analysis of 
the amino acid composition of these receptor subunits could be used to identify residues 
responsible for dictating synaptic versus extrasynaptic localization. The identification of 
accessory proteins from the ACR-2(L/S) suppressor screen suggests that this method can 
also be used to identify proteins required for the assembly and trafficking of synaptic 
AChRs. The high level of homology between C. elegans and mammalian genes suggests 
that critical amino acids and accessory proteins identified through these experiments will 
be directly applicable to understanding how AChRs function in the human brain.  
  
Pore-modified ACR-2(L/S) receptors provide insight into the molecular mechanisms of 
necrotic cell death 
 
Expression of pore-modified ACR-2(L/S) resulted in the paralysis of animals 
from hatch leading me to question how hyperactivation of cholinergic neurons effects cell 
survival.  Further investigation revealed vacuolar lesions along the ventral nerve cord and 
a reduction in the number of cholinergic cell bodies in the adult animal.  Genetic analysis 
confirmed that ACR-2(L/S) expression occurred through a necrotic-like mechanism 
around the time of hatch.  Necrotic-like cell death is a common result of hyperactivation 
in the brain after ischemic stroke (Hou and MacManus, 2002).  Understanding how 
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ionotropic receptor activation contributes to cell death is an important factor in mapping 
out mechanisms triggered in stroke patients, leading to potential therapeutic targets.  
Necrosis was originally thought of as a passive form of cell death that occurred as 
a consequence of cellular injury without requiring the activation of a specific genetic 
mechanism (Golstein and Kroemer, 2007b);(Kitanaka and Kuchino, 1999).  More recent 
work has shown evidence that this process can be induced through the activation of 
specific cell death receptors, though the cellular mechanisms controlling necrosis remain 
poorly understood (Galluzzi et al., 2011).  My work has shown direct evidence for a 
specific cellular mechanism underlying necrosis in motor neurons, contributing to the 
understanding of mechanisms that link AChR hyperactivation to necrotic cell death.  
Our model shows that hyperexcitation of the cell through expression of ACR-
2(L/S) leads to calcium-induced calcium release from the ER triggering downstream 
mechanisms that result in necrotic cell death of cholinergic motor neurons. The necrotic-
like cell body death observed in ACR-2(L/S) animals was suppressed by eliminating 
function of calreticulin and calnexin, proteins which sequester calcium within the ER.  
This work provides a pathway through which excess excitatory signaling can cause 
necrotic-like cell death in motor neurons, providing a new model to study the genetic 
underpinnings of excitotoxicity.   
The levels of excitation required to trigger necrotic cell death have not been fully 
described. In addition to ACR-2(L/S), a spontaneous gain-of-function in the ACR-2 
subunit has been identified that does not cause excitotoxicity.  This strain has a 
spontaneously occurring valine to methionine substitution at the 13th position of the 
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second transmembrane domain of the ACR-2 subunit phenotype (Jospin et al., 2009).  
Unlike ACR-2(L/S) which causes necrotic cell death, expression of ACR-2(V/M) leads to 
a spontaneous convulsion phenotype.  The significant differences in the functional results 
of these two gain-of-function receptors lends insight into the amount of excitation that 
motor neurons can tolerate before the necrotic cell death program is initiated. Comparing 
the relative strength of these gain-of-function mutations in this model system will allow 
us to further these initial studies by characterizing the biological consequences of altering 
neuronal excitability.    
 
Excitotoxic cell death occurs through differential mechanisms in the axon and cell body 
Suppression of cell body death failed to prevent the paralysis caused by ACR-
2(L/S) expression, suggesting that neuronal function was altered by a secondary 
mechanism independent of necrosis.   In lines carrying deletion mutations in both the 
calnexin and calreticulin genes, adult animals maintained a full complement of motor 
neuron cell bodies, though the animals remained paralyzed.   Further analysis revealed 
that these animals were able to move at hatch and became paralyzed because of the 
progressive degeneration of cholinergic motor neuron axons.  This finding suggested that 
the dying back of axons and cell soma death seen as a result of excitotoxicity may be 
genetically separable.  
Many neurodegenerative diseases feature a dying back phenomenon where 
degeneration begins at the distal tip of the axon and moves towards the soma (Fischer et 
al., 2004).  For example, analysis of the neuromuscular junction of ALS mouse models 
shows evidence for weakening of cholinergic synapses before the behavioral onset of 
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disease symptoms (Frey et al., 2000).  Similar progressive destabilization of cholinergic 
motor neuron axons was observed in ACR-2(L/S) animals with blocked cell body death.  
This provides evidence that this dying back phenomenon may be directly related to the 
hyperactivation of neurons by excess ionotropic receptor activation.  Recent studies have 
begun to characterize the molecular underpinnings of axonal degeneration, though the 
genetics remain poorly understood. My model for axon degeneration in a genetically 
tractable organism provides a model to study the molecular mechanism underlying 
axonal death.  The high level of homology between the C. elegans and mammalian 
genome suggests that these mechanisms will be conserved across species providing 
potential therapeutic targets for neurodegenerative disease.  
 
Future Directions 
 Though this work has lent insight into the mechanism underlying ion channel-
mediated cell death in motor neurons, further work is required to fully characterize the 
axon destabilization that occurs independently of cell body death.  I would propose a two 
pronged approach to this project: first I would characterize the progression of axon 
destabilization using morphological and behavioral analysis, and second, I would identify 
the genetic pathways regulating axon destabilization by performing a forward genetic 
screen for suppressors of axon destabilization in crt-1;cnx-1;ACR-2(L/S) mutant animals. 
I would begin by carrying out live-imaging experiments to document the progression of 
axon destabilization.  These experiments will provide a closer time course of 
destabilization and give us a better understanding of how axon branching occurs. Using 
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the axon destabilization experiments as a reference, I would also conduct synapse 
imaging experiments, which will allow me to document the progression of synapse loss 
in response to neuronal hyperactivity. 
In human neuromuscular diseases, synapse loss is thought to begin even before 
the onset of behavioral symptoms, a theory that can be easily tested in this C. elegans 
model. My previous work has shown that crt-1;cnx-1;ACR-2(L/S) animals are able to 
move normally at hatch but become paralyzed before the onset of the second larval stage.  
New worm tracking software available in the lab will allow for a more comprehensive 
study of this behavioral change by filming animals over a prolonged period of time and 
tracking the progression of paralysis. Pairing this detailed time course of paralysis with a 
microscopic analysis of synapses will lead to the establishment of a genetic model system 
to identify the molecular mechanism controlling axon destabilization and synapse loss in 
cases of hyperactivation.  
 These molecular mechanisms can be identified by carrying out a forward genetic 
screen using crt-1;cnx-1;ACR-2(L/S) animals as a sensitized background.  A primary 
screen for suppression of adult paralysis followed by a secondary screen examining axon 
morphology would lead to two major categories: animals with wild type movement and 
morphology and animals with branched axons and wild type movement.  I expect this 
first group to contain many of the same genes identified in my original screen for 
suppressors of ACR-2(L/S)-induced paralysis, including components of the receptor and 
receptor trafficking proteins.  The second group has the potential to identify interesting 
neuroprotective genes that are able to at least partially rescue axons from the effects of 
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hyperexcitation. This screen was not pursued originally due to the highly complicated 
genetic background that would make identification of suppressors using SNP mapping 
very difficult.  With recent advances in deep sequencing technology, including wide 
availability and lower cost, I believe that this screen could be revisited and yield 
interesting results.   
 
Part 2: Inactivation of cholinergic neurons disrupts neural circuit development 
 Disruptions in the balance of excitation and inhibition (E/I balance) in the 
developing mammalian brain has been linked to many neurological disorders including 
epilepsy and autism (Fritschy, 2008);(Rubenstein and Merzenich, 2003). In Chapter III, I 
characterized the roles of E/I balance in establishing and maintaining inhibitory synapses 
in the C. elegans motor circuit.  In this work, I show that loss of excitatory drive results 
in altered function and patterning of GABA synapses, though gross circuit morphology 
remained intact. Global reductions in neurotransmission are not sufficient to alter 
inhibitory synapse morphology but selective disruption of cholinergic neurons results in 
altered inhibitory synapses, establishing ACh motor neurons as master regulators of 
inhibitory synapse patterning.  I identified a four-hour critical period during the highly 
synaptogenic first larval stage when acetylcholine release onto GABA motor neurons is 
required to establish inhibitory synapse distribution.  Finally, loss of excitatory drive in 
the mature circuit resulted in a homeostatic decrease in inhibitory synapse size, which 
was reversed upon reintroduction of acetylcholine into the system (see Figure 4-2).   My  
work implicates excitatory motor neurons as master regulators of inhibitory synapse 
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development and provides evidence for activity-dependent synaptic plasticity in C. 
elegans neurons, a previously debated phenomenon. This work established a genetic 
model to study critical period development and homeostatic plasticity in an intact neural 
circuit.  Gaining a better understanding of these basic biological processes will lead to 
insights into the specifics of critical period plasticity disorders which are thought to 
contribute to many human neurological diseases.  
 
Activity-dependent control of neural circuit development 
In my work, I have shown that body wall muscle morphology is slightly altered in 
animals lacking cholinergic drive, with muscles extending 2-3 muscle arms per cell body 
rather than the 4-5 observed in wild type animals (Dixon and Roy, 2005a).  Despite this 
reduction in muscle arm number, there was no change in the area of the ventral nerve 
cord covered by muscle membrane. These results show a previously undescribed 
mechanism where muscle arms expand their domains through a possible homeostatic 
mechanism to cover the entire ventral nerve cord. This compensatory mechanism is 
reminiscent to a phenomenon observed in the tiling of neurons where loss of a neuron 
results in the invasion of its area by surrounding neurons of the same class.  These results 
uncover a novel mechanism for compensatory plasticity in the development of body wall 
muscles of C. elegans, a system that is classically thought to contain an invariable 
blueprint for the establishment of body architecture.  
In contrast, GABA motor neurons develop independently of excitatory 
presynaptic input.  Neuronal cell body positioning in animals lacking functional ACh 
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MNs (unc-3) or in animals where ACh MNs are killed early in development (ACR-
2(L/S)) are indistinguishable from wild type.  Commissural projections extend normally 
and travel to the dorsal musculature to form an intact dorsal nerve cord.  These results 
suggest that cell-intrinsic mechanisms are in place to instruct the birth and outgrowth of 
GABA motor neurons. Comparing the results in motor neuron versus body wall muscle 
shows that activity modulation has differential effects depending on cell types.  These 
differences in response to altered activity in different cell types further adds to the 
evidence supporting the model that C. elegans nervous system development is more 
plastic than originally thought.  
  
Roles for E/I balance in inhibitory synapse development 
The activity of the GABAergic nervous system plays an essential role in the 
establishment and refinement of neuronal networks within the mammalian brain (Ben-Ari, 
2002a);(Hensch and Fagiolini, 2005a). Though the importance of inhibitory activity 
during development is well established, little is known about inhibitory nervous 
development in vivo.  Through this work I show that excitatory drive onto GABAergic 
motor neurons during early development is an essential driving force behind inhibitory 
synapse patterning and function.  
Through electrophysiological analysis of inhibitory signaling, we observed that 
GABA motor neurons remain functional in the absence of excitatory input. This result 
implies that presynaptic activation of GABA motor neurons is not essential for neuronal 
function providing evidence for the existence of intrinsic activity within GABA motor   
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Figure 4-2:  Model- Excitatory input regulates inhibitory synapse development and 
function 
A. Loss of excitatory drive in the developing motor circuit leads to altered patterning of 
inhibitory synapses characterized by large gaps in synapse distribution and increased pre- 
and post-synaptic area.  These changes lead to the model that excitatory drive onto 
GABA motor neurons triggers an activity-dependent transcriptional or translational 
mechanism within these neurons that regulates the patterning or refinement of inhibitory 
synapses.  B. Reduced excitatory drive onto GABA motor neurons in the mature nervous 
system results in decreased synapse size, without altering synaptic patterning.  In this 
model, homeostatic mechanisms in the adult nervous system react to decreased activity 
levels by reducing inhibitory synapse size, functionally maintaining the balance of 
excitation and inhibition within the circuit.   
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neurons.  The frequency of spontaneous release events in these animals is reduced to 
approximately 1/3 of wild type, which reflected either a loss of presynaptic drive or 
alterations in synapse function.  Additionally, the amplitude of spontaneous release 
events was significantly increased, suggesting that while gross neuronal morphology 
remains intact, functional changes occur at the synapse as a result of decreased excitatory 
innervation. Consistent with our recordings of spontaneous release, we found that the 
amplitude of evoked GABA events was significantly increased in animals chronically 
lacking cholinergic function.  Taken together, functional analysis shows that while 
GABA motor neurons remain active in the absence of cholinergic input, the functional 
properties of the synapses are altered. This data shows that while motor neuron 
development is activity dependent, synaptic connectivity is highly influenced by changes 
in presynaptic input.   
Spontaneous activity has been observed in the developing nervous systems of many 
species and across multiple brain regions during periods when neural circuits undergo 
significant refinement (Katz and Shatz, 1996);(Blankenship and Feller, 2010); (Dehorter 
et al., 2012); (Feldt et al., 2011); (Moody and Bosma, 2005) leading to the theory that 
correlated spontaneous activity is responsible for circuit refinement.  The mammalian 
visual system has been widely used to study this theory, though many questions remain 
due to the limitation of anesthetizing animals, which inhibits patterns of spontaneous 
activity in the cortex (Hanganu et al., 2006); (Siegel et al., 2012).  In my studies, I used 
the genetic tools available in C. elegans to modulate the activity of a specific neuronal 
class to determine how neural circuit function and morphology were altered. We 
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observed an increase in GABA synapse size in the absence of functional cholinergic 
motor neurons, a result that was consistent with the increased GABA synaptic function 
we observed in our electrophysiology experiments. We also observed a decrease in 
synapse density in animals lacking cholinergic innervation. These results support the 
hypothesis that the circuit is not able to refine synapses in the absence of excitatory 
activity.  My work has provided a new model for the study of activity-dependent circuit 
refinement in a motor circuit where the genetic pathways underlying activity-dependent 
refinement can be directly studied.   
Studies in the mammalian cortex have shown a correlation between excitatory 
synapse size and synaptic efficacy. For example, at glutamatergic synapses, stronger 
synapses have larger dendritic spines and an increase in the number of glutamate 
receptors at the PSD (Matsuzaki et al., 2004a).  Our observation that increased GABA 
function in the absence of cholinergic innervation correlates to an increase in synapse 
size suggests that synapse size is also an indicator of synapse strength for inhibitory 
synapses. This result was particularly interesting due to the fact that GABA motor neuron 
morphology remained unaltered in these mutants, suggesting that there may be an 
activity-dependent mechanism that is required to establish inhibitory synaptic 
connectivity independently of neural wiring. 
 Global reductions in neurotransmission were insufficient to alter inhibitory 
synapse size or patterning. This result led me to the hypothesis that the balance of 
excitation and inhibition may regulate inhibitory synapse size and patterning. In contrast, 
mutant animals with selective disruption of GABAergic release failed to phenocopy the 
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synaptic patterning defects.  This result was further supported by evoked recordings from 
animals carrying a mutation in the transcription factor unc-30, which leads to loss of 
expression of essential GABAergic genes.  We observed no change in the amplitude of 
evoked cholinergic responses in these animals, further supporting the hypothesis that 
excitatory activity acts as a driving force for inhibitory synapse patterning.  
Cholinergic motor neurons synapse onto both body wall muscles and onto GABA 
motor neurons leading to two potential sites of action for the cholinergic instruction of 
inhibitory synapse patterning.  Blocking cholinergic neurotransmission onto the body 
wall muscle using animals lacking functional cholinergic receptors at the NMJ, unc-
29;acr-16, did not alter inhibitory synapse patterning. This result eliminated cholinergic 
signals onto the muscle as a potential mechanism for inhibitory synapse patterning.  I was 
unable to directly test the consequence of removing cholinergic neurotransmission onto 
GABA motor neurons because the full complement of receptors at this synapse has yet to 
be identified. To circumvent this problem, I used a mutant in the vascular acetylcholine 
transporter (vAChT) unc-17 to block all cholinergic neurotransmission in the motor 
circuit. The loss of acetylcholine release resulted in disruption of inhibitory synapses.  
This result supports the hypothesis that cholinergic release onto the GABA motor 
neurons is required to pattern inhibitory synapses.  Together, these results suggest a 
potential model where an activity dependent transcriptional or translational mechanism 
within the GABA motor neurons instructs GABA synapse patterning.  
 
Critical period control of neural circuit development 
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In the mammalian brain, the function of the inhibitory nervous system has been 
implicated as a key player in determining the timing of critical period plasticity (Fagiolini 
and Hensch, 2000a).  Multiple studies have shown the ability of GABA interneurons to 
control key aspects of cortical circuits including neuronal excitability, integration and the 
temporal oscillations of excitatory networks (Swadlow, 2003a);(Pouille and Scanziani, 
2001a);(Somogyi and Klausberger, 2005). 
Through my work, I have identified a four-hour critical period window during 
which cholinergic drive onto inhibitory motor neurons is required for the appropriate 
patterning of inhibitory synapses.  Loss of excitatory drive during this window leads to 
changes in inhibitory synaptic patterning that phenocopy the defects observed in animals 
chronically lacking functional cholinergic neurons.  Interestingly, there is no increase in 
the size of synapses in these animals, though there is a significant increase in synapse size 
in animals chronically lacking cholinergic release.  This suggests that the increase in 
synapse size may be a separate phenotype from changes in patterning and a second 
critical period window could exist to determine synapse size.  
In addition to providing new insights into the development of the inhibitory 
nervous system, these results also provide evidence for a new genetic model to study 
critical period windows during development. Identification of these pathways is the first 
step in understanding potential methods for reintroducing plasticity into the adult brain as 
a therapy for patients suffering from brain injury.  
 
Activity-dependent plasticity in modulating mature neural circuits 
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The primary function of a neuron is to receive information from presynaptic 
partners, integrate that information and provide appropriate synaptic output. The ability 
of the neurons to dynamically change synaptic strength is a key component in neural 
circuit function. Strong, repeated stimulation from a presynaptic cell strengthens synaptic 
connections, termed Hebbian plasticity, and has been studied as a cellular basis of 
learning and memory (Neves et al., 2008); (Sjostrom et al., 2008).   In order to prevent 
this process from leading to runaway excitation, homeostatic feedback mechanisms are 
thought to maintain network stability.  Studies of homeostatic mechanisms in mammalian 
cell culture have led to the identification of molecular properties of homeostatic plasticity 
but the lack of intact neural network connectivity may obscure specific aspects of control 
that are dependent on precise connectivity (Pozo and Goda, 2010).  These studies 
highlight the need for established in vivo systems for the study of homeostatic 
mechanisms in intact neural networks.  
My work has shown evidence of homeostatic plasticity in the motor circuit of C. 
elegans. I observed that when acetylcholine release is removed from the established 
motor circuit, a proportionate decrease in the size of GABA presynaptic release sites and 
postsynaptic clusters occurred.  Further, adding acetylcholine release back into the circuit 
led to a recovery of inhibitory synapse size back to wild type levels.  The synaptic scaling 
we observe in the established nervous system correlates to what is observed in circuits 
where homeostatic plasticity is functioning appropriately to maintain circuit function.  
For example, in hippocampal slices, reduction of network activity by TTX treatment 
leads to reduced mIPSCs in mature cultures, suggesting a decrease in inhibitory synapse 
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size (Hartman et al., 2006).  This data implies that activity-dependent mechanisms 
functioning in GABA motor neurons are different in the developing compared to the 
adult nervous system.  
Homeostatic plasticity is not only important in cases of hyperexcitation, it may 
also play a role in conditions of chronic reduced activity to increase synapse strength, 
preventing unnecessary synapse loss within the circuit (Vitureira and Goda, 2013).   In 
cases where excitatory drive was chronically lost, I observed an increase in both the size 
of inhibitory synapses and in the amplitude of spontaneous release events from GABA 
neurons.  These data suggest that homeostatic mechanisms may be in place to maintain 
GABA synaptic efficacy in cases of chronic activity loss.  
 
Future Directions 
 The clear next step in this project is to use an array of complementary genetic 
approaches to explore activity-dependent mechanisms regulating inhibitory synapses.  I 
have begun this analysis using an RNAi screen to evaluate the function of previously 
characterized synaptogenic genes at inhibitory synapses. The highly conserved gene 
neurexin was identified in this pilot screen as a regulator of inhibitory synapse formation 
in C. elegans validating this approach for screening synaptogenic genes (see Appendix).  
I would also like to compare gene expression levels in wild type animals versus 
animals lacking cholinergic innervation (unc-3).  Using deep sequencing and/or 
microarray analysis, hundreds of genes can be compared between these two groups, 
shedding insights into the role activity plays on gene expression. Any genes that show 
dramatic changes in expression provide us targets for further analysis, ultimately 
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resulting in the identification of activity-dependent pathways that regulate inhibitory 
synapse patterning.   
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Appendix 
 
Identification of genetic mechanisms required for the patterning of 
inhibitory synapses: Neurexin and Neuroligin. 
 
Belinda Barbagallo and Michael M. Francis 
 
 
 
Contribution Summary 
The following work was carried out in the lab of Dr. Michael M. Francis at the 
University of Massachusetts Medical School. In this chapter, Michael Francis provided 
advice on experimental design and data analysis.  I designed and carried out experiments 
and analyzed data.  
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Introduction 
Initial synapse formation begins when axons reach their target postsynaptic cell 
and requires a number of developmental steps, many of which are thought to be mediated 
by cell adhesion molecules (Gerrow and El-Husseini, 2006); (Dalva et al., 2007).  
Defects in genes responsible for the formation, stabilization and maintenance of synapses 
have been linked to many neurological disorders ranging from schizophrenia to autism, 
emphasizing the need to better understand the underlying molecular mechanisms of 
synapse development (Banerjee et al., 2014); (Jenkins et al., 2014)  
Two molecules that have been implicated in synapse development are the single 
pass transmembrane protein neurexin and its binding partner neuroligin. Recent genome 
sequencing studies have identified mutations in neurexin and neuroligin in patients with 
autism spectrum disorders, highlighting the importance of investigating roles for these 
genes in synapse development and function (Liu et al., 2012);(Camacho-Garcia et al., 
2012);(Camacho-Garcia et al., 2013). Neurexin and neuroligin form a trans-synaptic 
complex that interacts with the pre- and postsynaptic scaffolding networks and have been 
shown to recruit synaptic proteins in cell culture studies (Rao et al., 2000);(Scheiffele et 
al., 2000);(Graf et al., 2004); (Nam and Chen, 2005).  In contrast to cell culture studies, 
neurexin and neuroligin knock out mouse models do not show alterations in synapse 
morphology; instead they show defects in calcium mediated synaptic release structure 
(Missler et al., 2003);(Varoqueaux et al., 2006).  These results lead to conflicting models 
for neurexin and neuroligin function at synapses.  
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The conflicting results of these cell culture and mouse knock out models have 
been clarified by Drosophila studies at excitatory synapses though the function of these 
proteins at inhibitory synapses within an intact circuit remain uncharacterized. Recent 
studies have linked mutations in neurexin and neuroligin to autism spectrum disorders, 
highlighting the importance of elucidating roles for neurexin in the CNS (Liu et al., 
2012); (Camacho-Garcia et al., 2012); (Camacho-Garcia et al., 2013). This link to 
neurological disorders highlights the need for further in vivo studies of gene function to 
better understand the contradictions in cell culture versus mouse knockout models.  
Because the functional redundancy of splice isoforms complicates the study of neurexin-
neuroligin interactions in mammalian models, I turned to and invertebrate model to better 
understand neurexin and neuroligin function in the development of synapses. 
The C. elegans genome encodes four neurexin-like genes by sequence homology, 
with the gene nrx-1 encoding the most highly related homolog of mammalian neurexin 
(Tabuchi and Sudhof, 2002).  NRX-1 is expressed almost pan-neuronally and is localized 
specifically at presynaptic release sites, suggesting a role in synapse function (Haklai-
Topper et al., 2011).   Neurexin has been shown to interact with a retrograde signaling 
pathway at cholinergic neurons in C. elegans that controls presynaptic vesicle release and 
postsynaptic receptor density (Hu et al., 2012).  Roles for neurexin in the development 
and function of inhibitory synapses in C. elegans have not been identified.  
Here, we demonstrate that neurexin and neuroligin play an instructive role in the 
patterning of inhibitory GABA synapses.  We identified neurexin from an RNAi screen 
for modulators of GABA receptor patterning.  Neurexin loss of function mutant animals 
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show altered patterning of both pre and postsynaptic markers, characterized by large gaps 
in synapse distribution along the nerve cord.  In contrast to neurexin mutant phenotypes, 
neuroligin mutant animals show an increased coverage of inhibitory synapses at the 
ventral nerve cord. This suggests that neuroligin and neurexin do not have the same 
function during the development of inhibitory synapses.  Finally, genetic analysis 
suggests that neuroligin functions downstream of cholinergic motor neuron function 
while neurexin functions in a parallel pathway, further supporting the hypothesis that 
neurexin and neuroligin function in independent pathways to regulate the patterning of 
inhibitory synapses.   
 
Results 
 
A candidate mutant screen for genes required for synapse development 
 
My previous work has shown that loss of excitatory drive during early development 
results in altered patterning of inhibitory synapses within the C. elegans motor circuit, 
providing evidence for the existence of activity-dependent synaptic mechanisms.  In 
order to characterize the mechanisms underlying these activity-dependent changes, I 
carried out a pilot RNAi screen for genes that are required for inhibitory synapse 
patterning.  
In C. elegans, RNAi is delivered as dsRNA that can be administered to the animals 
by feeding, soaking or microinjection (Conte and Mello, 2003).  For initial screening, I 
chose to use a feeding method where animals were grown up for two generations on 
NGM plates seeded with bacteria expressing dsRNA for the gene of interest.  GABA 
receptor localization in adult F2 animals was imaged and the percent coverage of the 
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ventral nerve cord was calculated for each gene knockdown tested.  My initial screen 
included genes previously characterized as playing essential roles in nervous system 
development.  Of the genes screened, two RNAi lines produced alterations in GABA 
receptor localization: egl-15 and nrx-1 (Figure A-1).    
The gene egl-15 encodes the sole C. elegans fibroblast growth factor (FGF) receptor, 
which is orthologous to the vertebrate FGFR1-4 (DeVore et al., 1995)).  FGF receptors 
have been shown to be involved in presynaptic differentiation in the mouse hippocampus 
(Terauchi et al., 2010), leading to the hypothesis that the FGF receptor egl-15 in C. 
elegans mediates a similar effect.  Work done in C. elegans has shown that egl-15 
function is required for the development and outgrowth of muscle arm extensions (Dixon 
et al., 2006). This result led me to believe that the observed disruption in GABA 
receptors may be a secondary effect of altered muscle arm membranes, not a synapse-
specific phenotype.  Due to these findings, I did not pursue elg-15 as a candidate for 
further analysis.  
The second candidate that was identified from my pilot screen was nrx-1. nrx-1 
encodes C. elegans neurexin, a single-pass transmembrane domain protein that has been 
linked to synapse development. Neurexin interacts directly with its binding partner 
neuroligin and has been shown to be sufficient to recruit synaptic proteins in cell culture 
studies (Rao et al., 2000);(Scheiffele et al., 2000);(Graf et al., 2004); (Nam and Chen, 
2005).  Animals cultured on RNAi against nrx-1 showed a significant reduction in the 
amount of the muscle membrane extensions expressing postsynaptic receptors, with nrx-1 
RNAi strains showing 65% coverage compared to 90% in wild type (Figure A1-A).  The 
171
requirement for neurexin at GABAergic synapses was not previously explored in C. 
elegans making it an interesting candidate for further study.  
 
 
Characterization of inhibitory synapses in neurexin mutants 
 To further characterize the role of neurexin in inhibitory synapse development, I 
began by confirming the results from my RNAi screen by assessing inhibitory synapse 
patterning in animals carrying a deletion mutation in nrx-1.  nrx-1(ok1649) contains a 
861bp deletion in the nrx-1 gene that removes the C-terminus of all four splice isoforms 
of NRX-1, which encodes the PDZ binding motif.  The PDZ binding motif has been 
shown to be required for the exit of neurexins from the golgi and transport to synapses 
leading us to believe that this allele is acting as a null mutation (Fairless et al., 2008).   
 I expressed genetically encoded markers for both the inhibitory presynaptic 
release sites (Punc-47::mCherry::RAB-3) and postsynaptic receptors (UNC-49::GFP) 
and found that inhibitory synapse patterning was also disrupted in nrx-1(ok1649) mutant 
animals.  This disruption included large gaps in synaptic distribution resulting in 40% of 
the nerve cord lacking synapses in nrx-1 mutants, compared to 10% in wild type (Figure 
A2).   Presynaptic release sites and postsynaptic receptors remained aligned in nrx-1 
mutants suggesting that the localization of entire synapses, not synaptic registration, is 
altered.  These data further support the model that neurexin is required to localize 
inhibitory synapses at the C. elegans neuromuscular junction.  
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Neurexin and neuroligin work in opposing pathways to regulate inhibitory synapse 
density 
Cell culture studies have shown that neurexin interacts directly with another single 
pass transmembrane protein neuroligin to initiate synaptogenesis in cultured cells 
(Scheiffele et al., 2000);(Graf et al., 2004); (Nam and Chen, 2005). This leads to the 
hypothesis that the interaction between neurexin and neuroligin may also be mediating 
inhibitory synapse distribution in C. elegans.  In order to test this hypothesis, I began by 
fluorescently tagging inhibitory synapses in nlg-1(ok259) mutant animals and assessing 
synaptic patterning.  An increased area of both presynaptic release sites and postsynaptic 
receptor clusters is seen in these animals resulting in a near-complete coverage of the 
ventral nerve cord with synapses (Figure A-3C).  Quantification of this result shows a 
decrease in the percent of the nerve cord lacking postsynaptic markers from 20% in wild 
type to 5% in nlg-1 mutant animals indicating an increase proliferation of inhibitory 
synapse proteins (Figure A-3E).   These results suggest that neuroligin plays a role in 
inhibiting GABA synapse formation in a wild type circuit.  
We used pharmacological analysis to determine whether the physical changes we 
observed in neurexin and neuroligin mutant animals reflected functional changes in 
inhibitory synapses.  Aldicarb is an acetylcholinesterase inhibitor that prevents 
acetylcholine breakdown in the synaptic cleft, leading to a buildup of ACh and paralysis 
of the animals, providing a behavioral readout for synapse function.  nrx-1(ok1649) 
animals are hypersensitive to the paralytic effect of aldicarb suggesting that inhibitory 
synaptic function is decreased in these animals (Figure A-3F). This is consistent with the 
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decrease in the number of inhibitory synapses observed in these animals (Figure A-
3B,E).  In contrast, nlg-1(ok259) animals are resistant to aldicarb-induced paralysis 
suggesting increased inhibitory synapse function. This result is again consistent with the 
morphological analysis which showed increased coverage of inhibitory synapses in nlg-1 
mutant animals (Figure A-3C, E, F).  Taken as a whole, these experiments show that 
inhibitory synapse morphology and function are dependent on neurexin and neuroligin.   
Neuroligin has been shown to directly interact with neurexin to facilitate 
synaptogenesis. Interestingly, alterations in inhibitory synapse patterning in neuroligin 
mutant animals fail to phenocopy patterning defects observed in neurexin mutant animals 
suggesting that they do not always work in the same pathway.  In order to characterize 
the genetic interactions between neurexin and neuroligin in the C. elegans motor circuit, I 
evaluated inhibitory synapse patterning in nrx-1(ok1649);nlg-1(ok259) double mutant 
animals.  In these animals, inhibitory synapse patterning returns to near wild type 
distribution, which is reflected in the quantification of coverage (Figure A-3D, E).  In 
contrast, double mutant animals are hypersensitive to aldicarb-induced paralysis, 
phenocopying nrx-1 single mutants.  These differences in synapse patterning and synaptic 
function suggest that synaptic morphology and strength are not directly correlated.   
 
Excitatory activity works upstream of neurexin and neuroligin to pattern inhibitory 
synapses.  
My previous work has shown that cholinergic motor neuron function is required 
for inhibitory synaptic patterning. In order to determine if neurexin is working 
174
downstream of excitatory activity to pattern inhibitory synapses, we compared 
phenotypes in nrx-1 and unc-3 mutant animals. unc-3 encodes a transcription factor that 
is required for the terminal differentiation of cholinergic motor neurons.  Inhibitory 
synapse patterning is disrupted in unc-3 mutant animals showing large gaps in the 
distribution of synapses (Figure A-4B). These animals phenocopy the patterning defects 
in nrx-1 mutant animals, suggesting that neurexin may work downstream of cholinergic 
activity to drive inhibitory synapse development.  We tested this hypothesis by 
generating unc-3; nrx-1 double mutant animals and assessing changes in inhibitory 
synapse pattering to identify any genetic interactions. Inhibitory synapses are altered in 
nrx-1;unc-3 double mutants showing gaps in distribution as well as enlarged puncta size.  
Quantification of the percent of the nerve cord lacking postsynaptic receptors shows that 
the nrx-1;unc-3 double mutants show a more severe loss of synapse phenotype than 
either single mutant.  This additive effect suggests that neurexin and unc-3 work in 
parallel pathways to regulate inhibitory synapse distribution.   
In order to determine if neuroligin function was dependent on cholinergic activity, 
I also fluorescently tagged inhibitory synapses in unc-3;nlg-1 double mutant animals and 
assessed synapse morphology. Synapses in nlg-1;unc-3 double mutant animals show gaps 
in distribution and enlarged puncta. Synaptic morphology in these animals phenocopies 
the observed defects in nlg-1;nrx-1 double mutants (Figure A-4D, Figure A3).  The 
percentage of nerve cord lacking synaptic markers increases significantly from 5% in nlg-
1 single mutants to 30% in nlg-1;unc-3 double mutants.  These data suggest that nlg-1 is 
working downstream of both activity and neurexin to pattern inhibitory synapses.   
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Discussion and Future Directions 
 
Cell culture and mouse model studies paint different pictures of neurexin and 
neuroligin function at synapses, making it critical to carry out further studies in intact 
neural circuits. My work has used the C. elegans motor circuit to provide mechanistic 
insights into the function of neurexin and neuroligin in the development of inhibitory 
synapses and revealed potential links between gene function and the activity of upstream 
neurons.   
My data suggest that neurexin and neuroligin work in opposing pathways to 
instruct inhibitory synapse density, with neurexin promoting diffusion of inhibitory 
synapses and neuroligin working to cluster synapses in wild type animals.  These 
opposing functions differ from the more traditional pathway where neurexin directly 
binds neuroligin to recruit synaptic proteins.  Neurexin; neuroligin double mutant animals 
show a near wild type distribution of synapses, further supporting the model where 
neurexin and neuroligin function opposite each other to balance inhibitory synapse 
density. Functional analysis of these double mutant animals show that they phenocopy 
the aldicarb hypersensitivity seen in neurexin single mutant animals.  The differences in 
the severity of the physical and functional changes seen at inhibitory synapses suggests 
that synaptic morphology is not always a direct indicator of the level of functional 
changes at a synapse. Further analysis to identify the site of action for neurexin and 
neuroligin would be instrumental in understanding the mechanism regulating inhibitory 
synapse function in this circuit.  
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My previous work has produced a model where cholinergic motor neuron activity 
triggers an activity-dependent pathway in the GABA motor neurons that regulates 
inhibitory synapse patterning.  Based on inhibitory synapse phenotypes, neurexin was 
thought to play a role in this activity-dependent mechanism.  The double mutant analysis 
for unc-3;nrx-1 showed an additive phenotype where gaps in synapse distribution were 
larger in either single mutant.  This suggests that neurexin is working in a parallel 
pathway to cholinergic activity to regulate inhibitory synapses. These experiments also 
showed that nlg-1;unc-3 mutants closely phenocopied nlg-1;nrx-1 double mutants.  
These results suggested that neuroligin works downstream of both neurexin and activity, 
though the mechanisms linking neuroligin function to activity have yet to be identified.   
These experiments bring up many questions about the function of neurexin and 
neuroligin at inhibitory synapses.  What is the mechanism linking neuroligin to activity?  
How do activity levels alter transcriptional and/or translational levels of neurexin and 
neuroligin?  Determining the site of action for nrx-1 and nlg-1 function at inhibitory 
synapses and looking for differences in protein levels in wild type and unc-3 mutant 
animals could further address these questions. Additionally, a forward genetic screen for 
suppressors of inhibitory synapse patterning defects in a nlg-1 or nrx-1 mutant 
background can be used to determine other players in these pathways. The results of 
these experiments will lead to a better mechanistic understanding of neurexin and 
neuroligin function in an in vivo system.  
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Using C. elegans as a genetic model to identify genes required for inhibitory synapse 
development.   
 Identification of neurexin, a previously identified synaptogenic gene in 
mammalian cells, validates our approach for using C. elegans to identify key mechanisms 
underlying inhibitory synapse development.  This leads to a two-pronged approach to 
broaden our knowledge of inhibitory synapse development.  Further RNAi screens will 
allow us to characterize previously identified genes in a simple genetic system. Many 
genes are highly conserved between C. elegans and the mammalian genome allowing us 
to test them in our model system.  C. elegans is amenable to many genetic manipulations 
that are lethal in other systems, allowing for the study of essential synaptogenic genes.   
In addition to RNAi screens, we are able to carry out forward genetic screens for 
genes required for inhibitory synapse development.  This non-biased approach allows us 
to identify previously uncharacterized synaptogenic genes.  Using the genetically 
tractable C. elegans system to quickly identify and characterize molecular pathways that 
can be further studied in mammalian systems will quickly push the field forward.  
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Figure A-1: RNAi knockdown of neurexin disrupts the patterning of GABA 
receptor clusters.  
A. Quantification of the percent of the ventral nerve cord of adult animals expressing 
GABA postsynaptic receptor clusters (UNC-49::GFP)  in wild type animals grown for 
two generations on the RNAi lines indicated.  The graph shows data for control strains 
(black bars), positive hits (nrx-1 in red, egl-15 in white) and negative results (gray bars). 
Bars represent the mean ±SEM of at least ten animals /RNAi line.  Student t-test. 
***p<0.0001, **p<0.01.  B-D: Confocal images of UNC-49::GFP expressing animals 
grown on empty vector (B), nrx-1(c29A12.5) (C) or beta integrin(C05D9.3) (D) RNAi 
plates.  Brackets indicate gaps in receptor clusters in the nrx-1 animals.  Scale bar: 20uM.  
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Figure A-2: Inhibitory synapse patterning is disrupted in neurexin mutant animals.  
 A-C: Confocal images of the posterior ventral nerve cord of adult animals co-expressing 
a GABA presynaptic marker (Punc-47::mCherry::RAB-3) with a GABA postsynaptic 
receptor marker (UNC-49::GFP).  Brackets indicate gaps in synapse distribution.  Scale 
bar: 20uM. D. Quantification of the percent of the ventral nerve cord lacking presynaptic 
release sites.  Graph represents the mean ±SEM for at least ten animals/genotype. Student 
t-test: *p<0.01, ***p<0.0001. 
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Figure A-3: Neurexin and neuroligin have differential effects on inhibitory synapse 
distribution.  
A-D: Confocal images of the posterior ventral nerve cord of adult animals co-expressing 
a GABA presynaptic marker (Punc-47::mCherry::RAB-3) and a GABA postsynaptic 
receptor marker (UNC-49::GFP). Brackets indicate gaps in synapse distribution; dotted 
lines indicate areas of diffuse synapse clustering. Scale bar: 20uM.  E. Quantification of 
the percent of the ventral nerve cord lacking presynaptic release sites.  Graph represents 
the mean ±SEM for at least ten animals/genotype. Student t-test: **p<0.001.  F. Paralysis 
time course for animals in the presence of the cholinesterase inhibitor aldicarb (1mM).  
The percentage of immobilized animals was calculated every 15 minutes; the graph 
represents the mean ±SEM of at least ten trials/genotype, with populations of 10-15 
animals/trial.   
  
183
 
 
 
  
Wild Type
nrx-1(ok1649)
nlg-1(ok259)
nlg-1(ok259);nrx-1(ok1649)
%
 o
f n
er
ve
 co
rd
lac
kin
g 
re
ce
pt
or
 cl
us
te
rs
10
20
30
40E
Wi
ld T
ype
nrx
-1(
ok1
649
)
nlg
-1(
ok2
59)
nrx
-1(
ok1
649
;
nlg
-1(
ok2
59)
)
**
**
ns
A
B
C
D
F
184
 
Figure A-4: Neurexin and neuroligin work downstream of cholinergic motor neuron 
activity to pattern inhibitory synapses.  
A-F: Confocal images of the posterior ventral nerve cord of adult animals co-expressing 
GABA synapse markers (Punc-47::mCherry::RAB-3 and UNC-49::GFP) in the 
genotypes indicated.  Brackets indicate gaps in synapse distribution. Scale bar: 20uM.  G: 
Quantification of the percent of the ventral nerve cord lacking postsynaptic receptor 
clusters in control animals (black bars), neurexin mutant animals (gray bars) and 
neuroligin mutant animals (white bars).  The graphs represent the mean ±SEM for at least 
ten animals/genotype.  Student t-test: **p<0.01, ***p<0.000.  
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